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Flavonoids are a group of naturally occurring low molecular weight 
phenolic compounds commonly found in a wide variety of plants, including 
the most common finits and vegetables. The basic structure of flavonoid 
consists of two benzene rings linked up by a C3 pyrone group, at which 
different chemical groups attached characterized the types of flavonoid. The 
most abundant types of flavonoids are flavones and flavonols. Flavonoids 
appear to be the active constituents found in many medicinal plants, and they 
are widely used in traditional medicine and as food supplements. Recent 
researches have shown that flavonoids exhibit diverse biological effects, 
including anti-allergic, anti-inflanmiatory, immunomodulatory, anti-viral and 
anti-tumoral activities. Although the importance of flavonoids is becoming 
more prominent when their anti-oxidant and anti-carcinogenic mechanisms are 
unraveled, yet their effects on the growth of leukemia cells and their 
therapeutic potentials remain poorly understood. 
The murine myelomonocytic leukemia cell line WEHI-3B JCS is a 
subcloned and well-characterized myeloid leukemia that can be induced to 
differentiate along the monocytic pathway by a wide variety of inducers, t i 
this thesis project, the WEHI-3B JCS cells were used as the cell model in 
studying the cellular and molecular actions of flavonoids on the growth, 
differentiation and survival of the leukemia cells. 
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Abstract 
In the present study, using the [^H]-thymidine incorporation assay, it 
was found that non-cytotoxic concentrations of flavone and 3-hydroxyfIavone 
(flavonol) inhibited the proliferation of leukemia JCS cells in a dose-
dependent manner. Similar results were obtained from using other parameters 
for measuring cell growth and proliferation, such as the trypan blue dye 
exclusion assay and the MTT assay. Moreover, different flavone and flavonol 
derivatives exerted anti-proliferative activities on the JCS cells. The results 
show that flavonol exhibited the most potent cytostatic activity on JCS cells 
(IC50 = � 1 0 |LdVO，followed by myricetin, flavone and 6-hydroxyflavone. Jn 
contrast, morin hydrate was much less effective in inhibiting the proliferation 
ofJCS cells (IC50 = 200 |uM). Among the different tumor cell lines tested for 
their sensitivities to the growth-inhibitory effect of flavone and flavonol, the 
murine myeloid leukemia JCS and Ml cell lines were found to be the most 
sensitive. Results in this study also show that the colony-forming ability of 
JCS cells in vitro and their tumorigenicity in vivo were also inhibited by 
flavone-treatment of the JCS cells. Li view of the potent anti-proliferative 
activity of flavonoids on JCS cells, the differentiation-inducing activity of 
flavone and flavonol on JCS cells was assessed using a number ofphenotypic 
and functional criteria. Flavone and 3-hydroxyflavone were shown to have the 
capacity of inducing the monocytic differentiation of the myeloid leukemia 
WEffl-3B JCS cells dose-dependently. Furthermore, the fIavonoid-treated 
JCS cells had acquired the functional characteristics of mature macrophages, 
such as increased spreading and adherence to plastic surface, induction ofNBT 
reducing and non-specific esterase activities, as well as stimulation of 
endocytic and phagocytic activities. ^ addition, flavone was also found to 
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induce the DNA fragmentation in JCS cells. Results in this study show that 
the induction of differentiation by flavone in JCS cells was associated with 
DNA fragmentation, a characteristic of apoptosis. 
Previous studies had suggested that the physiological differentiation 
inducers or cytokines could act individually and also cooperatively in inducing 
the differentiation of leukemia cells. So the combining effects of flavone and 
physiological inducers (all-trans retinoic acid ATRA and 1,25-
dihydroxyvitamin D3) as well as cytokines (interferon-y (EFN-y), interleukin-
l a and ip (EL-la & DL-ip)) were made in the current study with regard to 
their anti-proliferative and differentiation-inducing activities on JCS cells. 
The combination of flavone and physiological inducers, including ATRA and 
1,25-dihydroxyvitamin D3 and cytokines including rmEL-la and rmDL-ip, 
were found to enhance the anti-proliferation and act synergistically in inducing 
monocytic differentiation of the leukemia JCS cells in vitro. 
Furthermore, the molecular mechanism by which flavone can induce 
monocytic differentiation ofJCS cells was studied by the technique ofReverse 
Transcription-Polymerase Chain Reaction (RT-PCR). The present fmdings 
show that flavone can induce or enhance the expression of certain cytokine 
genes, such as tumor necrosis factor-a (TNF-a), macrophage colony-
stimulating factor (M-CSF), leukemia inhibitory factor (LEF), interleukin-la 
(EL-la) and interleukin-6 (EL-6), suggesting that the expression of these 
cytokine genes may be instrumental to leukemic cell differentiation. 
vii 
； Abstract 
It is hoped that these preliminary results, together with those done by 
others, would allow a better understanding of the molecular mechanisms and 
signaling pathways involved in the hematopoietic cell proliferation and 
differentiation. Hence, the novel treatments for leukemia, based on restoring 
the normal cell differentiation and maturation process, can be developed with 
higher specificity and less toxicity. 
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� Ch. 1 General Introduction 
1.1 An Overview on Hematopoiesis 
1.1.1 Development of Hematopoietic Stem Cells and Sites of 
Hematopoiesis 
Hematopoiesis is known as the process ofblood cell formation. It is an 
ordered process in which stem cells differentiate into functional mature cells 
through sequential cell division and differentiation. The primary sites of 
hematopoiesis differ at different time oflife. 
Ln humans, during the first few weeks of gestation, the yoU^ sac is the 
main site of hematopoiesis. From 6 weeks to 6-7 months of fetal life, the 
major organs involved are liver and spleen and they continue to produce blood 
cells until about 2 weeks after birth. Soon after birth, the hematopoietic 
population declines in both liver and spleen (Hoffbrand and Pettit, 1993). 
From 6-7 months to adult life, over 95% ofhematopoietic tissue is located in 
the bone marrow ofthe central skeleton and proximal ends ofthe femurs and 
humeri (Metcalf and Moore, 1971). 
]n fact, hematopoiesis is regarded as the development of the self-
renewal stem cells to the mature progenies in a tightly arranged hierarchy. 
First, the pluripotent stem cells (1 per 10^  marrow cells) continually 
proliferate, renew themselves and also give rise to common progenitor cells, 
and then differentiate to immature progenitor cells of various blood cell 
lineages (1% of hematopoietic cells). Following further differentiation, the 
mature functional blood cells (10^ maturing progenies generated by each 
progenitor cell) in the eight major lineages are formed (Metcalf, 1995). Along 
the hematopoietic pathway, they are increasingly differentiated along multiple 
1 
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cell lineages, and they progressively lose their ability for self-renewal (Fig. 1.1) 
(Dexter and Spooncer, 1987). 
The terminally differentiated blood cells generally lose their ability to 
proliferate and they are rather short lived (Balkwill, 1989). Therefore, there 
must be a continual production ofblood cells, which is known as hematopoiesis 
to maintain the numbers of certain type of blood cells in a steady-state 
(Meager, 1990). 
C^ Pluripotent stem cell StCHl CcllS 
^ ® ^ _ 
0 ( f ^ Myeloid stem ceU ？ M 
^ ^ \ '；感 z V ^ " ^ P " 
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T ;; I I I r ^ Cells 
I o ' 0 • • • • • rn 
I pre-TceIls | pre-Bcells CFU.^  CFlW CFUoM 綱他‘ B^ , J 
| i 0 C F W ^ 
1 0 I O ® ® ® ® ® ® MaturingCells 
^11 i 过 eosinophilbasophilneutr^ l^^ llj^ ocyt^ egakaryoc r^— 
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Figure 1.1: Diagrammatic representation of the principal components in 
hematopoiesis. Baso: basophil; BFU: burst-forming unit; CFU: colony-forming unit; 
Eosin: eosinophil; Ery: erythroid; GM: granulocyte-macrophage; Meg: megakaryocyte 
[modified from Alberts et al. (1994) and Hoffbrand and Pettit (1993)]. 
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1.1.2 Role ofCytokines in the Control ofHematopoiesis 
The strict and complex regulation on the continual replacement and 
replenishment of stem cells and mature blood cells in hematopoiesis had 
widely been studied. The development of normal hematopoietic cells was 
analyzed by the establishment of an in vitro culture system for the clonal 
expansion and differentiation of normal hematopoietic cells (Ichikawa et al., 
1966 and Metcalf and Burgess, 1982). This cell culture system greatly 
assisted in the discovery of a family of hematopoietic and growth factors, 
which are known as cytokines that can regulate cell viability，multiplication 
and differentiation of different hematopoietic cell lineages (Whetton and 
• 
Dexter, 1993; Sachs, 1995). 
Recently, a number ofhematopoietic cytokines have been molecularly 
cloned and purified. A family of four different colony-stimulating factors 
(CSFs) have been discovered. They include macrophage colony stimulating 
factor (M-CSF), granulocyte colony stimulating factor (G-CSF), granulocyte-
macrophage colony stimulating factor (GM-CSF) and interleukin-3 (EL-3 or 
Multi-CSF), which are relatively lineage-specific and stimulate the growth and 
proliferation of certain responsive cells of a restricted cell lineage. For 
example, M-CSF stimulates the development of monocyte/macrophage 
colonies and enhances their survival in vitro (Bmgger et aL, 1991). However, 
colony stimulating factors are not solely the proliferative stimuli ofresponsive 
cells, they have four additional in vitro actions to cope with the normal 
hematopoiesis. They are the enhancement of the survival of precursors and 
mature cells by maintaining the functional integrity of the cell membrane, 
irreversible induction of differentiation commitment, induction of cellular 
‘ 3 
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maturation and stimulation ofthe functional activity of mature cells (Metcalf, 
1989; Metcalfand Nicola, 1995). 
Besides the colony stimulating factors, other regulatory cytokines, such 
as IL-1 and IL-6 have been found to enhance the effects of colony stimulating 
factors, maintain the viability and induce the differentiation of normal myeloid 
precursor cells, yet they do not have the colony stimulating ability (Lotem et 
al., 1989). Experiments on the normal myeloid precursors have shown that all 
four colony stimulating factors can induce the production of IL-6, which can 
induce the myeloid precursors to differentiate into macrophages, granulocytes 
or megakaryocytes. The induction of differentiation factor by other growth 
factors can serve as an effective mechanism to couple growth and 
differentiation. EL-6 can then switch on other factor(s) that is/are required to 
determine the specificity ofthe final cell type. These altogether suggested that 
hematopoietic cytokines function in a network of interactions (Lotem et aL, 
1991; Sachs, 1995). 
The production of specific cell types was stopped when sufficient cells 
have been produced. This requires a balance between inducers and inhibitors 
of development to act as homeostatic regulators of hematopoiesis. The 
inhibitory cytokines in the cytokine networks, such as transforming growth 
factor p (TGF-p), macrophage inflammatory protein-la (MEP-la), tumor 
necrosis factor a (TNF-a), interferon a and y (ffN-a & EFN-丫)，were found to 
selectively inhibit the activity of certain colony stimulating factors, 
interleukins and hence, inhibit the proliferation of various precursor and 
progenitor cells (Lotem and Sachs, 1990; Clemens, 1991; Lotem et al., 1991). 
4 
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1.2 Leukemia and Cell Differentiation 
1.2.1 Leukemia as Abnormalities in Hematopoietic Cell Development 
Leukemia is regarded as blood cell disorder caused by the uncoupling 
of proliferation and differentiation at various stages along the hematopoietic 
pathway, so that the immature precursor cells accumulate, retain their 
proliferative ability without completing the differentiation program 
(Hoffbrand and Pettit, 1993). 
There are approximately 17,000 new cases of hematological 
malignancy each year in Britain, and the chance of occurrence has been 
estimated as one person in 100 in Westem countries. These conditions are not 
common in young people and there are about 450 cases of childhood leukemia 
in Britain each year. About 90% cases of leukemia and related disease occur 
in adults. Although less than 10% ofall cases ofleukemia affect children, it is 
the most common cancer (32%) in pediatric population, and this is caused by 
the high incidence ofacute lymphoblastic leukemia (ALL) (80% - 90% of all 
cases) in childhood. Li contrast, chronic lymphoblastic leukemia (CLL) 
occurs almost exclusively late in life (Campbell, 1995). 
5 
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1.2.2 Classification and Etiology ofLeukemia 
Leukemia can be classified into acute and chronic leukemia, according 
to the onset, duration of the disease and also the morphology and 
cytochemistry of the leukemia cells (i.e. the degree of proliferation and 
differentiation ofthe leukemic clone in bone marrow). As a result, in patients 
suffered from acute leukemia, there are over 50% myeloblasts in their bone 
marrow, whereas the bone marrow infiltrates of chronic leukemia consist 
mainly ofdifferentiated cells (Hoffbrand and Pettit, 1993). Both the acute and 
chronic leukemia can be further subdivided into myeloid and lymphocytic 
leukemia on the basis of morphology and cytochemistry (Goasguen et al., 
1996). 
The acute myeloid leukemia (AML) is further subdivided into eight 
variants, and the nomenclature is based on the French-American-British 
(FAB) classification scheme proposed in 1976 (Table 1.1). On the other hand, 
the acute lymphocytic leukemia (ALL) has been classified by the FAB group 
into three groups according to the size of the leukemia cells. The chronic 
myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) are 
grouped into six and seven categories respectively (Table 1.1) (Hoffbrand and 
Pettit, 1993; Sheer, 1991). 
In case of leukemia, the accumulation of immature, non-functional 
precursor cells results in replacement of the normal hematopoietic cells of 
bone marrow, which ultimately caused bone marrow failure, with several 
clinical symptoms, such as anemia, bleeding, spontaneous brushing, fever, 
malaise, fatigue and increased susceptibility to infection. The infiltration of 
6 
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leukemia cells can cause the enlargement of spleen (splenomegaly), liver 
(hepatomegaly) and lymph nodes (lymphoadenopathy). Moreover, the 
symptoms of central nervous system involvement may be observed, such as 
severe headache, nausea and vomiting. Patients may also be suffered from 
gout and renal impairment owing to the hyperuricaemia resulting from 
excessive purine breakdown (Hoffbrand and Pettit, 1993). 
From the study of experimental and naturally occurring leukemias in 
animals, it was found that irradiation, chemical carcinogens and viruses may 
play a role in the development ofthis disease. It is clear that from the atomic 
bomb experience in Japan, radiation can cause or initiate acute and chronic 
myeloid leukemia in humans (Greaves, 1991). The radiation from nuclear 
power installation and low-frequency electromagnetic fields have also caused 
childhood leukemia. The long term exposure to chemicals and drugs, for 
example, benzene, chloramphenicol, phenylbutazone and especially smoking, 
may be leukemogenic (Campbell, 1995). The association ofleukemia with the 
infectious leukemia virus, such as the adult T-leukemiaAymphoma vims, 
Epstein-Barr vims OEBV) and immunologically compromised person, for 
instance, heart or kidney recipients and patients with acquired 
immunodeficiency disease syndrome (AE)S) has been well documented. 
Moreover, there is an increased prevalence of lymphocytic leukemia found in 
patients with hereditary immunodeficiency states (Greaves, 1991). 
7 
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Table 1.1: Classification ofleukemias. 
~ ~ f ^ ~ ~ Subclass Variant 
- ~ MO: minimal differentiation 
Ml: myeloblastic (>90% myeloblasts) 
M2: myeloblastic with granulocytic maturation (>10% 
promyelocytes or later granulocytes) 
Acute Myeloid M3: promyelocytic 
Leukemia (AML) M4: myelomonocytic (>20% granulocytes and >20% 
^ monocytes) 
M5a: monoblastic 
Acute M5b: monoblastic with differentiation 
M6: erythroleukemia (>50% erythroblasts) 
M7: megakaryoblastic (>50% megakaryoblasts) 
“ L1: homogeneous small blasts with little cytoplasm 
Acute Lymphoblastic L2: heterogeneous larger blasts with variable amounts of 
Leukemia (ALL) cytoplasm 
L3: homogeneous larger blasts with vacuolated basophilic 
cytoplasm 
“ ‘ Philadelphia-positive chronic myeloid leukemia 
Philadelphia-negative chronic myeloid leukemia 
Chronic Myeloid Juvenile chronic myeloid leukemia 
Leukemia (CML) Chronic neutrophilic leukemia 
Eosinophilic leukemia 
Chronic myelomonocytic leukemia 
Chronic B-chronic lymphocytic leukemia 
B-prolymphocytic leukemia 
Chronic Lymphoblastic Hairy cell leukemia 
Leukemia (CLL) Plasma cell leukemia 
T-chronic lymphocytic leukemia 
T-prolymphocytic leukemia 
Adult T-cell leukemia/lymphoma 
(Greaves, 1991; Hoffbrand and Pettit, 1993; Goasguen et al., 1996) 
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1.2.3 Current Modalities for the Treatment ofLeukemia 
Conventionally, leukemia patients are treated with cytotoxic drugs 
aiming to damage the capacity of cells for reproduction or eradication of the 
proliferating neoplastic cells (Tritton and Hickman, 1990). Cytotoxicity is 
mediated in several ways. Anti-metabolites like methotrexate inhibit the 
synthesis of pyrimidine and purine nucleotides or their incorporation into 
DNA. On the other hand, alkylating agents (e.g. cyclophosphamide) and 
DNA binding agents (e.g. adriamycin) interfere with mitosis by cross-linking 
to or intercalating into the DNA (Hoffbrand and Pettit, 1993). However, apart 
from the development of drug resistance, most of these chemotherapeutic 
drugs having their own side effects such as causing nausea, vomiting, 
mucositis, bone marrow toxicity and even infertility at larger doses (Hoffbrand 
and Pettit, 1993). 
Radiotherapy and bone marrow transplantation are also the methods 
commonly used in curing leukemia. However, there are limitations existed 
due to the toxicity on normal cells for radiotherapy and the requirement for 
matching ofbone marrow for transplantation. As a result, there is great need in 
the search of new promising therapeutic strategies. 
9 
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1.2.4 Leukemia Cell Lines as In Vitro Models for the Study of Myeloid 
Leukemia 
There is accumulating evidence that various myeloid leukemia cells, 
including the murine (Ml, R453, WEHI-3B) and human (HL-60, K562, KG-1, 
ML-1 and ML-3) myeloid leukemia cells, can be induced to differentiate into 
cells with the normal characteristics of mature myeloid cells. The cells cease 
to proliferate and lose their transplantability into animals, in which terminal 
cell differentiation occurs (Hozumi, 1983). Therefore, the induction of 
terminal differentiation of myeloid leukemia cells can have important 
implications in the therapy of leukemia and some common differentiation 
inducers are listed in Table 1.2. 
A wide variety of chemical compounds, other than the normal 
hematopoietic regulatory cytokines, can induce the differentiation in D+ clones 
of myeloid leukemia cells to mature macrophages and granulocytes. These 
include certain steroid hormones, chemotherapeutic drugs (such as cytosine 
arabinoside, adriamycin, methotrexate), X-irradiation, surface-acting agents 
and vitamin A and D3 analogs (Olsson et al., 1990; Sachs, 1993). The 
differentiation can be achieved either by direct interaction with DNA 
(Hozumi, 1983), or indirect induction of other differentiation inducers (Sachs, 
1978). 
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Table 1.2: Some common inducers of myeloid cell differentiation. 
Type of compounds Inducers 












Surface-acting agents Concanavalin A 




Vitamins ‘ Vitamin A and vitamin A analogs (retinoids) 
Vitamin D3 (la, 25-dihydroxyvitamin D3) 




Polycyclic Hydrocarbons Benzopyrene 
Dimethylbenzanthracene 
Others Arginase 





(Sachs, 1978; Hozumi, 1983; Gabrilove, 1986; Olsson etal., 1990) 
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1.2.5 Cytokines as Inducers ofMyeloid Leukemia Cell Differentiation 
Besides the chemical inducers mentioned in Section 1.2.4, more 
recently, cytokines have also been found to interfere with leukemic cell growth 
and differentiation. The conditioned medium of mouse embryo cells, which 
can induce macrophage and granulocyte differentiation ofthe mouse myeloid 
leukemia cell line Ml, was first discovered by Ichikawa in 1969. 
The growth-inhibitory, differentiation-inducing and apoptosis-inducing 
cytokines were found to suppress the malignancy of myeloid leukemia with the 
following three characteristics (Sachs, 1993): 
(i) Malignancy can be suppressed either with or without genetic changes 
in the tumor cells; 
(ii) Suppression of malignancy by inducing differentiation does not restore 
all the normal controls, and 
(iii) Genetic abnormalities which give rise to malignancy can be bypassed 
and their effects nullified by inducing differentiation and apoptosis 
which stop cells from multiplying. 
Therefore, the hematopoietic cytokines can stop cell multiplication by 
inducing the differentiation via alternative pathways in D+ clone of myeloid 
leukemia cells, and these alternative pathways bypass the genetic changes that 
inhibit the response to the normal differentiation inducers (Sachs, 1993). 
12 
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Cytokines such as, IL-6, TNF-a, G-CSF, GM-CSF，IL-1, IL-4 and 
DFN-y, etc. were found to regulate the growth and differentiation of a number 
of myeloid leukemia cell lines (Hozumi, 1983). They can act alone or 
synergistically to induce differentiation and inhibit the proliferation of 
leukemia cells. For instance, IL-4 and TNF-a were found to act 
synergistically in the induction of monocytic differentiation of a murine 
myeloid leukemia cell line, WEHI-3B JCS (Leung et al., 1994). Ln 
conclusion, hematopoietic cytokines interact in a complex network, which is 
of critical importance in regulating the growth, differentiation and survival of 
hematopoietic cells. 
1.2.6 The Murine Myeloid Leukemia Cell Line OVEHI-3B JCS) as an 
Experimental Cell Model 
The murine myelomonocytic leukemia cell line (WEHI-3B JCS) was a 
characterized subclone of the WEHI-3B (D') line. Various WEffl-3B 
subclones (D+，D' and JCS) retained some common characteristics, like 
producing IL-3 (Mak et al,, 1993). However, each of them has its unique 
characteristics and response to the differentiation inducers. For example, after 
the addition ofendotoxin semm or G-CSF, only WEHI-3B D+，but not WEffl-
3B D' nor JCS gave the dispersedy'semi-dispersed macrophage and 
macrophage-granulocyte differentiated colonies (Mak et al., 1993). 
There is clear evidence that the WEHI-3B JCS can be readily induced 
to differentiate into mature, non-proliferative cells through exposure to various 
compounds. Among such inducing agents are certain cytokines such as 
TNF-a, IL-la, IL-ip, EFN-y, as well as non-physiological inducers, including 
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phorbol 12-myristate 13-acetate (PMA) and lipopolysaccharide (LPS) (Mak et 
al., 1993; Leung et aL, 1994 and Chan et al., 1995). Synergistic actions of 
growth factors to induce differentiation of JCS were also observed. It was 
reported that sub-optimal concentrations of TNF-a (20 units/ml) and JFN-j 
(300 units/ml) were able to induce monocytic differentiation of JCS cells 
(Mak et al, 1993). Similar interaction was also observed when JCS cells were 
treated with TNF-a (50 units/ml) and IL-4 (100 units/ml) (Leung et al., 1994). 
As a result, this myeloid leukemia cell line represents an excellent cell model 
for studying myeloid leukemia cell growth and differentiation since it provides 
homogeneous populations of immature myeloid cells that can be induced by a 
variety of agents to undergo differentiation in vitro. Besides, this induced 
differentiation process is similar to that of normal myeloid cells, in which the 
induced cells are morphologically and functionally similar to normal mature 
macrophages. 
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1.3 Flavonoids: Properties and Biological Activities 
1.3.1 Chemical Structure and Classification ofFlavonoids 
Flavonoids have existed in nature for over one billion years (Harbome 
et al., 1975). Over 4000 chemically unique flavonoids have been identified in 
all vascular plants and they are widely consumed in food of plant origin and 
the amount can be up to lg in daily Westem diet (Middleton and Kandaswami, 
1993). The compounds are benzo-y-pyrone (or 2-phenyl-chromone) 
derivatives with the basic structure of Ce-C3-Ce (Figure 1.2). They are 
comprised of a benzene ring A and three-carbon pyrone group, carrying a 
substitutent ring B either in 2-position (flavonoid) or 3-position (isoflavonoid). 
For example, flavones and flavonols differ from each other by a hydroxyl 
group in the 3-position (Figure 1.3). Flavonoids may occur as aglycones (the 
basic form), glycosides (with sugar residues) or methylated derivatives, and 
flavones and flavonols are the most abundant types of natural-occurring 
flavonoids (Hollman et al., 1995). 
3， 
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Figure 1.2: The basic structure of flavonoid. 
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Figure 1.3: The main classes of flavonoids. The basic structure contains a benzene 
ring A and B, carrying a three-carbon pyrone group, which is known as ring C. The 
flavones and flavonols differ from each other by a hydroxyl group substituted in the 
3-position ofthe three-carbon pyrone group. Adapted from Holhnan et al., 1995. 
1.3.2 Occurrence and Distribution ofFlavonoids 
Flavones and flavonols which are the most widely occurring ( � 8 0 % ) 
flavonoids in nature (Tang, 1992; Wollenweber, 1993). The flavonoid 
aglycones usually occur externally oft the plant surface, or associated with the 
secretory structures, such as resin. The flavones and flavonols are found in 
genera of Primelea or Primula (Swain, 1976). Flavone (2-phenyl-y-
benzopyrone) was isolated from Primula malacoides, Pimelea decora and 
Primelea simplex (Wollenweber, 1993). 
It is known that the flavonoid glycoside contents of 40 species of 
medicinal plants, including Anthemis nobilis and Viola tricolor, have been 
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used as pharmacological agents. Ln addition, flavonoid aglycones have also 
been found in different parts of the medicinal plants, such as in Citrus peel, in 
the leaves of Eriodictyon glutinosum, Orthosiphon spicatus and other 
Lamiaceae, rhizome of Alpinia officinarum, herbs of the Asteraceae and bud 
exudate of certain poplars (Wollenweber, 1993). Li fact, there are numerous 
studies on the biological and pharmacological activities of flavonoids 
(Middleton and Kandaswami, 1993; Middleton, 1996). 
1.3.3 Biological Properties and Action Mechanisms ofFlavonoids 
Epidemiological studies around the world have consistently shown that 
a high intake of fruits and vegetables is associated with a low incidence of 
most types of cancer (Hirayama, 1985). Since flavonoids are abundant in food 
and medicinal plants used in folk medicine, so the pharmacological and 
biological actions of flavonoids have extensively been studied. Many ofthem 
are potent anti-oxidants, anti-inflammatory, anti-allergic, anti-viral, anti-toxic, 
hepatoprotective and enzyme-inhibiting substances (Middleton and 
Kandaswami, 1993; Boik, 1996). For instance, flavonoids also inhibit the 
enzymes involved in inflammation and allergy (lipoxygenase & 
cyclooxygenase) and superoxide production QSfADH oxidase & mitochondrial 
succinoxidase) (Korkina and Afanas, 1996). The flavonols such as quercetin, 
fisetin and luteolin are inhibitors of protein kinase C, protein tyrosine kinase 
and topoisomerase (Middleton and Kandaswami, 1993). 
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Many studies have shown that flavonoids can act as anti-oxidants. 
They can scavenge the oxygen free-radicals or reduce the production of free 
radical species either by chelating the metal ions or inhibiting a wide range of 
enzymes involved in the process of free-radical production including 
cyclooxygenase, lipoxygenase, microsomal monooxygenase，glutathione S-
transferase, mitochondrial succinoxidase and NADH oxidase (Korkina and 
Afanas, 1996). Flavonoids were also shown to protect the cells and tissue 
against free-radical-mediated damage. For example, flavonoids (quercetin, 
kaempferol, catechin and taxifolin) suppressed the cytotoxicity of superoxide 
ion and hydrogen peroxide on Chinese hamster V79 cells ON[akayama et aL, 
1993; Nakayama, 1994). Furthermore, flavonoids also protected a variety of 
cells such as erythrocytes, hepatocytes, kidney cells and cardiocytes against 
hypoxic injury, they are also effective protectors of the rabbit heart damage 
induced by ischemia/reperfusion (Wu et aL, 1994). Many flavonoids are also 
protective against free-radical-mediated injury by ionizing irradiation, the anti-
clastogenic effect of flavonoids may be attributed to the hydroxyl radical 
scavenging potency and/or the inhibition of oxygen radical-generated enzymes 
(Shimoi et aL, 1994; Korkina and Afanas, 1996). 
Flavonoids also have modulatory effects on cellular components of the 
immune system and inflammatory response, including T-cells, B-cells, 
macrophages, NK-cells, basophils, mast cells, neutrophils, eosinophils and 
platelets (Middleton and Kandaswami, 1992; Middleton and Kandaswami, 
1993). Flavonoids can also inhibit allergic reactions by inhibiting the 
production and release ofhistamine by inhibiting the enzymes including cyclic 
AMP phosphodiesterase, calcium-dependent ATPase and lipoxygenase (Boik, 
L8 
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1996; Middleton, 1996). The cytostatic effect of flavonoids on blastogenesis 
of normal human lymphocytes had been reported (Hirano et al., 1994). They 
also suppressed the mitogen-induced lymphocyte proliferation and mixed 
lymphocyte culture (Namgoong et al., 1993). 
The flavonoids also affect the endocrine system. Davis and co-
workers (1983) reported that quercetin suppressed thyroxine stimulation of 
human red blood cells' Ca^^-ATPase activity in vitro and inhibited the binding 
of the hormone to red blood cell membranes. Several other flavonoids 
including fisetin, hesperetin, tangeretin and chalcone were also shown to 
^ . 
reduce the sensitivity of membrane Ca -ATPase to hormonal stimulation 
(Davis et aL, 1983). Li addition, the phytoestrogen isoflavone formononetin 
causes the syndrome of infertility of sheep, in which formononetin is 
transformed by gut microflora to equol. Equol is a weak estrogen, which 
competitively antagonizes estradiol-17 beta equol binding to cytoplasmic 
estrogen receptors (Shutt and Cox, 1972). 
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1.3.4 Effects ofFlavonoids on Leukemia 
Flavonoids are regarded as anti-tumoral and anti-carcinogenic agents, 
they can act by blocking the action of carcinogens andA>r tumor promoters, 
and by suppressing the evolution of initiated cells. These actions can be 
achieved by inhibiting the metabolism of non-carcinogenic compounds into 
carcinogenic compounds, inducing enzyme systems that detoxify carcinogens 
(such as glutathione s-transferase and the cytochrome P450 enzyme system), 
scavenging free radicals and preventing tumor promoters fi:om reaching or 
reacting with their cellular targets (Boik, 1996). 
Various flavonoids are known to inhibit the growth and proliferation of 
certain leukemic cell lines. They have been shown to be potent cytostatic 
agents against the human leukemic HL-60 cells and T lymphocytic leukemia 
cell line MOLT-4 QHrmo et al., 1994). The flavonol, quercetin, also exerts 
anti-proliferative action on human leukemic K562 cell line (Csokay et al., 
1997) and various acute myeloid leukemia (AML) and acute lymphoid 
leukemia (ALL) cell lines (Larocca et al., 1991). The flavonoids were found 
to be suppressive against RNA, DNA and protein synthesis, as measured by 
the incorporation of [^H]thymidine, [^H]uridine and [^H]leucine into the HL-
60 cells (Hirano et al., 1994), and they also inhibited the clonogenicity of 
leukemia cells in soft agar (Csokay et al., 1997). 
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Recent findings have shown that the inhibitory effect of flavonoids on 
leukemic cell growth is associated with events of cell cycle arrest, DNA 
fragmentation and apoptosis (Constaninou et al., 1990; Austin et al., 1992; 
Yoshida et al., 1992). For example, quercetin can arrest CEM human 
leukemic T-cells in late Gi phase ofthe cell cycle (Yoshida et aL, 1992). The 
effect of flavonoids on cell cycle progression may be resulted from its direct 
action as an inhibitor oftyrosine kinase and the phosphorylation ofthe tyrosine 
ofp34cdc2/^yciin B complex during late S and early G2 phase (Traganos et al., 
1992). So the flavonoid addition resulted in growth suppression of leukemia 
which was associated with the accumulation of cells in the Go/Gi and G2M 
phases. 
The Citrus flavone tangeretin also induced the DNA fragmentation and 
programmed cell death (apoptosis) in human leukemic HL-60 and MOLT-4 
cells lines (Hirano et aL, 1995). The oligonucleotide DNA-fragments ( � 1 8 0 
bp) pattem appeared on the agarose gel electrophoresis of DNA. The DNA 
cleavage was due to the activation of a specific endogenous endonuclease 
(Cotter et al., 1990)，anchor the magnesium- (Mg�+-) and calcium- (Ca�+-) 
dependent endonucleases (Hirano et al., 1995). Moreover, the DNA strand 
breakage induced by flavones and genistein was resulted from the inhibition of 
topoisomerase H of human leukemic HL-60, K562 and MOLT-4 cell lines 
(Constaninou et al.，1990; Austin et aL, 1992; Traganos et aL，1992). 
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Apart from the anti-proliferative activity, flavonoids have also been 
j 
shown to exhibit differentiation-inducing activity on various leukemia cells. 
For example, flavonoids were reported to be capable of inducing the 
differentiation of murine erythroleukemia cells (Kinoshita et al., 1985) and 
quercetin was found to be a differentiation inducer of human leukemia K562 
cells (Csokay et al., 1997). Moreover, according to the studies of Sugiyama 
and co-workers (1993), flavones isolated from the fruit peel of Citrus 
reticulata Blanco (Rutaceae) showed the differentiation inducing activity 
towards mouse myeloid leukemia cells (Ml) and human acute promyelocytic 
leukemia cells (HL-60). Li addition, the phagocytic activity of the leukemia 
cells was also increased in case of flavone addition (Sugiyama et al., 1993). 
Changes in morphology, benzidine-staining and other functional activities of 
the mature leukemia cells were also observed upon flavonoid treatment 
(Kinoshita et al., 1985; Wantanabe etal., 1989; Sato etaL, 1994). 
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1.4 Aims and Scopes ofThis Investigation 
Flavonoids are a broadly distributed class of naturally occurring 
phenolic compounds found in a wide variety of plants, including most 
common fruits and vegetables. They are widely used in traditional medicine 
and as food supplements. Although the importance of flavonoids is becoming 
more prominent in this decade when their anti-oxidant and anti-carcinogenic 
effects are unraveled, yet their therapeutic potentials have not been fully 
explored. More recently, flavonoids have been shown to display profound 
effects on the proliferation and differentiation of a variety of leukemia cell 
lines in vitro, but the underlying cellular and molecular mechanisms by which 
flavonoids can modulate the growth, differentiation and survival of leukemia 
cells remain obscure. It is well-documented that the proliferation and 
differentiation of certain myeloid leukemia cells (e.g. WEHI-3B JCS and Ml 
cells) can be modulated by pharmacological agents such as PMA (Mak et al., 
1993) and a number of hematopoietic cytokines including TNF-a, EL-1, EL-4 
and LEF (Mak et al., 1993; Leung et al., 1994; Chan et al., 1995; Lau, 1996). 
Therefore, these cells have provided excellent models for the studies of 
hematopoietic cell proliferation and differentiation. 
The major aims of this investigation are to examine the effects of 
flavonoids on the proliferation, differentiation and apoptosis of myeloid 
leukemia cells. Li particular the possible interactions of flavonoids with 
physiological compounds such as cytokines and vitamins in modulating 
leukemia cell growth and differentiation will be studied. Moreover, the 
modulatory effect of flavonoids on cytokine gene expression in myeloid 
leukemia cells will be analyzed, as this will provide better insights into the 
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underlying mechanism of leukemic cell differentiation. 
Ln this project, a clonally derived murine myelomonocytic leukemia 
cell line WEHI-3B JCS will be used as the cellular model in studying the 
regulation of leukemic cell proliferation and differentiation. Since flavones 
and flavonols are the most widely occurring flavonoids, they will be used as 
prototypes for investigating the effects of flavonoids on leukemic cell growth 
and differentiation. The anti-proliferative activity of flavonoids on JCS cells 
will be determined by hemacytometer cell counting as well as measured by a 
standard [^]-thymidine incorporation assay. Li addition, the ability of JCS 
cells to form colonies in soft agar will also be examined. On the other hand, 
the differentiation-inducing activity of flavonoids will be assessed by a 
number of phenotypic and functional criteria such as the morphological 
changes, surface expression of lineage-specific differentiation antigens, 
increase in non-specific esterase activity as well as the induction ofphagocytic 
and endocytic activities. Li the present study, attempts will also be made to 
examine whether flavone can induce apoptosis in JCS cells. Moreover, the 
effect of flavone on the cell cycle kinetics of JCS cells will also be analyzed 
by flow cytometry. 
Moreover, various physiological differentiation-inducers, including 
cytokines and vitamin analogs, will be investigated for their ability to interact 
with flavone in modulating the proliferation and differentiation ofJCS cells. 
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Finally, the molecular mechanisms for the differentiation-inducing 
activity offlavone on the JCS cells will be studied by the technique ofReverse 
Transcription-Polymerase Chain Reaction (RT-PCR). The effect of flavone 
on the cytokine gene expression during the time course of JCS cell 
differentiation will be monitored. The specificity of the PCR products will be 
determined by dot-blot hybridization using specific oligonucleotide probes and 
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2.1 MATERIALS 
2.1.1 Cell lines 
(1) The murine myelomonocytic leukemia cell line WEHI-3B D" was 
originally obtained from Dr. D. Metcalf (Walter and Eliza Hall Listitute for 
Medical Research, Melbourne, Australia) and subsequently subcloned at 
the John Curtin School of Medical Research, Canberra, Australia. One of 
the subclones derived from the D" line was designated as WEHI-3B JCS 
(Maket aL, 1993). 
(2) The murine myeloblastic leukemia cell line Ml was derived from a 
spontaneous myeloid leukemia of SL strain mice (Ichikawa, 1969). It was 
kindly obtained from the Experimental Hematology Group, the John 
Curtin School ofMedical Research, Canberra, Australia. 
(3) The human promyelocytic leukemia cell line HL-60 was originated from a 
36-year-old Caucasian female. It was purchased from the American Type 
Culture Collection (ATCC). 
(4) The murine macrophage-like cell line PU5-1.8 (a spontaneous 
macrophage-like tumor originated from BALB/c mice) was obtained from 
the Department ofPathology, University ofCambridge，U. K. 
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(5) The murine macrophage-like cell line P388D1 (a methylcholanthrene-
induced tumor derived from the DBA/2 mice) was purchased from ATCC. 
(6) The murine Ehrlich Ascites tumor cell line EAT is an ascites derivative of 
a spontaneous murine mammary adenocarcinoma (tetraploid subline Ny 
Klein strain) and was kindly obtained from Prof. K. P. Fung, Department 
ofBiochemistry, the Chinese University ofHong Kong. 
(7) The murine fibroblast cell line L929 (a transformed fibroblast cell line 
derived from C3H mice) was kindly obtained from the Department of 
Pathology, University of Cambridge, U. K. 
(8) The murine primary fibroblast MH 3T3 was derived from the embryonic 
fibroblast o fMH Swiss mice, and it was obtained from ATCC. 
(9) The murine lymphoma YAC-1 cell line (a Moloney virus-induced T cell 
lymphoma of AJSn mice) was purchased fi:om ATCC. 
(10) The murine lymphoma MBL-2 cell line (a Moloney virus-induced T cell 
lymphoma of C57 BL/6J mice) was purchased from ATCC. 
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2.1.2 Mice 
Lnbred female BALB/c mice, aged 6-8 weeks were bred at the 
University Animal House of the Chinese University of Hong Kong under 
pathogen-free condition. They were fed with animal diet (Chow 5001, Rodent 
Laboratory) and given tap water ad libitum. 
2.1.3 Flavonoids 
The flavonoids used in this study were primarily the hydroxyl-
substituted flavones and 3-hydroxyflavone derivatives (Table 2.1). They were 
freshly prepared by dissolving in absolute ethanol (Riedel-de Haen) or 
dimethyl sulfoxide (DMSO) (Sigma Chemical Co.) as 0.1 M stock solution 
just before use. Only flavone was dissolved in ethanol and the other flavone 
and 3-hydroxyflavone (flavonol) derivatives were dissolved in DMSO. They 
were diluted in RPMI medium and the fmal concentration of ethanol and 
DMSO in the culture medium was never exceeded 0.2% (v/v). 
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Table 2.1: Summary of flavonoids used in the study of tumor cell proliferation 
and differentiation 
~~ Chemical Position Formula Solvent Sources of Purity 
Flavonoids formula of weight flavonoids % 
hydroxyl (g) 
group 
Flavone C15H10O2 - 222.24 Ethanol Acros >99 
, Organics 
6-Hydroxyflavone C15H10O3 6 238.25 -
7-Hydroxyflavone C15H10O3 7 238.28 99 
Chrysin C15H10O4 ^ 254.24 _ 
(5,7 Dihydroxyflavone) 
Flavonol Q5H10O3 3 238.25 Aldrich 99 
(3-Hydroxyflavone) Chemical 
Co. 





~~~*Quercetin dihydrate C15H10O7.2~~3,3',4', 338.26 Acros 99 
(3,3',4%5,7- H2O 5，7 Organics 
Pentahydroxyflavone) 
*Morin hydrate C15H10O7 2 ' ,3 ,4 ' , 302.24 95 
(2，，3，4’，5，7- 5,7 Aldrich 
Pentahydroxyflavone) Chemical 
Co. 
*Myricetin CisHioOg 3,3 ' ,4 ' , 318.24 -
(3，3，，4，，5,5，，7- 5，5，, 7 
Hexahydroxyflavone) 
* hydroxyl substituted derivatives of flavonol 
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2.1.4 Recombinant Cytokines 
(1) Recombinant Murine Literleukin-la (rmK^-la) and Literleukin-lp (rmEL-
1P) 
LL-la and BL-ip were purchased from R&D Systems Lic. They were 
o 
Escherichia co//-derived and had a specific activity of 1x10 units/mg as 
measured in a cell proliferation assay using the murine helper T cell line 
D.10.G4.1 (Symons etal., 1987). 
(2) Recombinant Murine Gamma Literferon (nrJFN-y) 
rmEFN-y was purchased from Boehringer Mannheim. It was derived 
from Escherichia coli and had a specific activity of 5xlO^ units/mg, as 
determined by the inhibition of cytopathic effect of encephalomyocarditis 
^)MC) virus on L-cells (mouse transformed fibroblasts) (Gray and 
Goeddel, 1983). 
All recombinant cytokines were prepared in sterile phosphate-buffered 
saline (PBS) containing 2% heat-inactivated fetal calf semm (HI-FCS). 
Small volume aliquots of stock solutions were stored at -20°C and thawed 
only once. The working solutions were kept at 4°C and used within one 
month. “ 
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2.1.5 Physiological Differentiation Inducers - Vitamin Analogs 
(1) Vitamin A, All Trans Retinoic Acid (ATRA) 
All trans retinoic acid (ATRA) was purchased from Sigma Chemical 
Co. It was dissolved in dimethyl-sulfoxide (DMSO). Small volume 
aliquots of 50 mM stock solution were protected from light and kept at 
-20°C. 
(2) 1,25-Dihydroxy-Vitamin D3 C^itamin D3) 
Vitamin D3 was purchased from Calbiochem-Novabiochem 
Corporation. It was dissolved in ethanol. Small volume aliquots of 0.2 
mM stock solution were protected from light and kept at -20°C. 
2.1.6 Monoclonal Antibodies 
(1) Rat anti-mouse CDlla (lymphocyte function-associated antigen-1, LFA-1 
ocL chain) monoclonal M17/4, rat IgG2a isotype was purchased from 
Pharmingen. The purified antibody reacts with the ocL subunit ofthe LFA-1 
(CDlWCD18, 0cLP2 integrin). 
(2) Rat anti-mouse macrophage CDllb (Mac-1) antigen monoclonal antibody 
(clone Ml/70, rat IgG2b isotype) was obtained from the culture supernatant ‘ 
ofthe hybridoma cell line Ml/70 (ATCC). 
(3) Rat anti-mouse macrophage differentiation antigen F4/80 monoclonal 
antibody (clone C1.A3-1, rat IgG2b isotype) was obtained from the culture 
supernatant of the hybridoma cell line F4/80 (ATCC). 
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(4) Rat anti-mouse CD54 (intercellular adhesion molecule-1, ICAM-1) 
monoclonal antibody (clone BE29G1, rat IgG isotype) was obtained from 
the culture supernatant of the hybridoma cell line BE29G1 (American 
Type Culture Collection). 
(5) Rat anti-mouse CD106 (vascular cell adhesion molecule-1, VCAM-1) 
monoclonal antibody (clone 429, rat IgG2a isotype) was purchased from 
Pharmingen. The purified antibody specifically binds with VCAM-1. 
(6) Fluorescein isothiocyanate (FITC)-conjugated goat anti-rat IgG antibody 
was purchased from Southern Biotechnology Associates Lic. The purified 
antibody reacts specifically with rat IgG and does not react with other 
heavy chain isotypes. 
32 
Ch. 2 Materials & Methods 
2.1.7 Buffers, Culture Medium and Other Reagents 
(1) Culture Medium 
RPMI 1640 medium, supplemented with 25 mM N-2-hydroxy-ethyl-
piperazine-N'-2-ethane-sulfonic acids (HEPES) and 2mM L-glutamine, 
was purchased from GEBCO BRL Life Technologies, Lic. The culture 
medium was prepared in distilled water and buffered with 25mM sodium 
bicarbonate CN a^HCOa) according to the manufacturer's specification. It 
was then sterilized by filtration through (0.22 i^m) millipore filter. 
The plain medium was supplemented with 100 units/ml penicillin G 
sodium, 100 ^gy'ml streptomycin sulfate and 250 ng/ml fungizone 
(amphotericin B) (PSF, GffiCO BRL Life Technologies Inc.) and 10% 
fetal calfsemm for cell passages or 10% heat-inactivated fetal calf serum 
for differentiation induction experiments. 
(2) Fetal Calf Semm (FCS) 
Fetal calf serum was purchased fi:om GffiCO BRL Life Technologies, 
Inc. and stored as 20 ml aliquots. Heat-inactivated fetal calf serum (HI-
FCS) was prepared as 10 ml aliquots by heating at 56�C for 30 minutes. 
Both kinds of semm were stored at -20°C. 
(3) Dulbecco's Phosphate-Buffered Saline (PBS) 
PBS (Sigma Chemical Co.) was prepared by dissolving the salt (0.2 g 
monobasic potassium phosphate, 0.2 g potassium chloride, 8 g sodium 
chloride and 1.15 g anhydrous dibasic sodium phosphate) in one liter of 
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distilled water. The pH ofthe solution was then adjusted to pH 7.4. Itwas 
sterilized by autoclaving at 121°C for 15 minutes. 
(4) Scintillation Fluid 
Scintillation fluid was prepared by mixing 12 g 2',5-diphenyloxazole 
(PPO), 1.2 g 2,2'-p-phenylene-bis-[5-phenyloxazole] OPOPOP), 2 liters 
toluene and 1 liter Triton X-100. The suspension was then stirred 
ovemight until the PPO and POPOP were completely dissolved and was 
stored at room temperature in dark. 
(5) Nonidet P-40 CNfP-40) Lysis Buffer 
The NP-40 lysis buffer was prepared in 50 mM Tris [hydroxyknethyl] 
amino methane (Tris)-HCl, pH 7.5 containing 3% NP-40 non-ionic 
detergent (Sigma Chemical Co.) and 20 mM ethylenediamine tetra-acetic 
acid ^X)TA) (Sigma Chemical Co.). 
(6) Propidium Iodide (PI) DNA Staining Solution 
The propidium iodide DNA staining solution was freshly prepared in 
PBS containing 0.1% Triton X-100 (Sigma Chemical Co.), 10 mM EDTA 
(pH 7.4) (Sigma Chemical Co.), 0.1% trisodium citric acid (Sigma 
Chemical Co.), 50 g^y^ ml propidum iodide (Sigma Chemical Co.) and 
400 i^g/ml ribonuclease A (RNase A) (Boehringer Mannheim). The 
staining solution was pre-chilled at 4°C before use. 
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(7) Nitroblue Tetrazolium O ^ T ) - Phorbol 12-Myristate 13-Acetate (PMA) 
Solution for Reactive Oxygen Species Detection 
NBT (Sigma Chemical Co.) was dissolved in RPMI supplemented with 
20% heat inactivated-fetal calfsemm (HI-FCS). 
(6) MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-Diphenyl Tetrazolium Bromide) 
MTT (Sigma Chemical Co.) was dissolved in PBS as 5 mg/ml stock 
solution and stored in dark at 4°C 
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2.1.8 Oligonucleotide Primers and Internal Probes 
For the study of cytokine gene expression utilizing the reverse-
transcription polymerase chain reaction (RT-PCR), the specific pair of 
oligonucleotide primers was designed according to the published sequence of 
its cloned cDNA. They were designed to prime on the sense and antisense 
sequence of the corresponding cDNA respectively (Table 2.2). 
]n addition, the specificity of the PCR products can be verified by dot 
blot hybridization. An oligonucleotide probe, which is specific for the 
interested gene, was synthesized and labeled at the 3，end with digoxigenin 
(DIG) (Table 2.2) using the DIG oligonucleotide 3'end labeling kit 
(Boehringer Mannheim). 
All oligonucleotides used in the gene expression study were kindly 
provided from Prof. M. C. Fung, Department of Biology, the Chinese 
University ofHong Kong, Hong Kong. 
36 
Ch. 2 Materials & Methods 
Table 2.2: Summary of the nucleotide sequences of primers and internal probes 
used in RT-PCR and hybridization studies. 




GAPDH upper primer ACC ACA GTC CAT GCC ATC AC 452 
lower primer~~TCC ACC ACC CTG TTG CTG TA 
~ ~ T N F ^ upper primer~~TCC CCA AAG GGA TGA GAA GTT C 4U 
lower primer~~~TCA TAC CAG GGT TTG AGC TCA G 
internal probe CAC ACT CAG ATC ATC TTC TC 
~M-CSF upper primer~~GTA GCC ACA TGA TTG GGA ATG G 304 
lower primer~~TCA TGG AAA GTT CGG ACA CAG G 
internal probe GTT CTG CTC CTC ATA GTC CTT G 
L 5 upper primer~~TCT CTT CAT TTC CTA TTA CAC AGC i I s 
lower primer~~GAC CAC CAC ACT TAT GAC TTG C 
internal probe CAC GGT ACT TGT TGC ACA GAC 
~ ~ n . . l a upper primer"""ACA GTA TCA GCA ACG TCA AGC AA~~ 546 
lower primer~~CCG ACT TTG TTC TTT GGT GGC A 
internal probe GGC AAC TCC TTC AGC AAC ACG 
DL^ upper primer~~TGA GAA AAG AGT TGT GCA ATG GC~ 479 
lower primer~"GAA TGT CCA CAA ACT GAT ATG CTT 
internal probe GTT AGG AGA GCA TTG GAA ATT GG~~ 
54 
Ch. 2 Materials & Methods 
2.1.9 Reagents for Cytokine Gene Expression Study 
(1) DEPC-Treated Distilled Water 
The distilled water used for the study of cytokine gene expression was 
treated with 0.1% diethyl pyrocarbonate (DEPC), (Sigma Chemical Co.), it 
was shaken thoroughly to disperse the DEPC, and the solution was then 
autoclaved to destroy the remaining DEPC. 
(2) Tris-HCl Buffer, pH 7.5 
Tris [hydroxylmethyl] amino methane (Sigma Chemical Co.) was 
prepared as 1 M stock solution in DEPC-treated distilled water. The pH of 
the buffer was adjusted to 7.5 with hydrochloric acid (HC1) and then 
autoclaved. 
(3) Guanidine Thiocyanate Solution (GT solution) 
Guanidine thiocyanate (Sigma Chemical Co.) was prepared as a 4 M 
solution in DEPC-treated distilled water and buffered with 0.1 M Tris-
HCl, pH7.5. It was then autoclaved and stored at room temperature. 0.1 M 
2-mercaptoethanol (Sigma Chemical Co.) was added to the solution before 
use. 
(4) Ultrapure dNTP set, 2'-Deoxynucleoside 5'-Triphosphate, Sodium Salt 
The deoxynucleoside triphosphate (dNTP) set was purchased from 
Pharmacia Biotech, with each nucleotide supplied as 100 mM solution in 
distilled water Q}H 7.5). The stock solution containing 10 mM of each 
dNTP was prepared in 1 mM Tris-HCl, pH 7.5 and was stored at -20°C. 
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(5) TioEo.iBuffer 
10 mM Tris-HCl (pR 7.5) and 0.1 mM EDTA 
(6) rRNasin (Recombinant Ribonuclease L:ihibitor) 
The recombinant RNasin ribonuclease inhibitor (Promega Corporation) 
was derived from Escherichia coli. The inhibitor was supplied in a storage 
buffer of 20 mM HEPES-potassium hydroxide, pH 7.6 (HEPES-KOH), 
50 mM potassium chloride (KC1), 8 mM dithiothreitol (DTT) (GEBCO 
BRL Life Technologies Lic.) and 50% (v/v) glycerol. One unit was 
defined as the amount of rRNasin required to inhibit by 50% the activity of 
5 ng of ribonuclease A as measured by the inhibition of hydrolysis of 
cytidine 2，，3'-cyclic monophosphate. 
(7) Oligo-dTi2-i8, sodium salt (pd(T)12-i8, sodium salt) 
Oligo-dT12-i8 was purchased from Promega Corporation. Stock 
solution of 1 ^ gy^ l^ was prepared in TioEo.i buffer and stored at -20°C. 
(8) First Strand Buffer 
The first strand buffer (GffiCO BRL Life Technologies Jnc.) was 
obtained as a 5X solution of250 mM Tris-HCl (pH 8.3)，375 mM KC1 and 
15 mM magnesium chloride (MgCl2). 
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(9) Moloney Murine Leukemia Virus (MMLV) Reverse Transcriptase 
The MMLV reverse transcriptase (GEBCO BRL Life Technologies 
Lic.) was isolated from Escherichia coll The enzyme was supplied in a 
storage buffer of 20 mM Tris-HCl (pH 7.5)，1 mM DTT, 0.01% (v/v) 
NP-40, 0.1 mM disodium EDTA Q^aiEDTA), 0.1 M sodium chloride 
fhJaCl) and 50% (v/v) glycerol. One unit of MMLV-reverse transcriptase 
was defined as the amount of enzyme that incorporates 1 nmole 
deoxythymidine triphosphate (dTTP) into acid-precipitable material in 10 
minutes at 37°C, using poly(A) and oligo-dTn-is as template and primer 
respectively (Houts et al.，1979). 
(10) Reaction Buffer W (lOX) 
The reaction buffer W (Advanced Biotechnologies Ltd.) was obtained 
as a 10X solution of200 mM ammonium sulphate (psrH4]2SO4), 750 mM 
Tris-HCl (pH 9.0) and 0.1% (w/v) Tween®. 
(11) ThermoprimePius DNA Polymerase 
ThermoprimePius DNA Polymerase (Advanced Biotechnologies Ltd.) 
was isolated from Thermus icelandicus, which has 5’ to 3，polymerase-
dependent exonuclease replacement activity but lacks the 3，to 5， 
exonuclease activity. The enzyme was supplied in a storage buffer of 50% 
(v/v) glycerol, 10 mM potassium phosphate, pH 7.0，100 mM NaCl, 
0.1 mM EDTA, 2 mM DTT and stabilizers. One unit of enzyme was 
defined as the amount of enzyme that incorporates 10 nmoles of dNTP into 
acid insoluble materials in 30 minutes at 74°C under the described analysis 
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conditions: 25 mM Tris-[hydroxymethyl]-methyl-amino-propane-sulfonic 
acid, sodium salts (TAPS), pH 9.3 at 25�C, 50 mM KC1, 2 mM MgCl2, 
1 mM 2-mercaptoethanol, 250 ^M of deoxycytidine triphosphate (dCTP), 
deoxyguanosine triphosphate (dGTP), deoxythymidine triphosphate 
(dTTP), 250 ^M [^]-deoxyadenosine triphosphate ([^]-dATP) (specific 
activity of 0.05 Ci/mmole), 1.25 ^ig/pl activated salmon sperm DNA in a 
total volume of 50 ^1. 
(12) Gel Loading Solution 
The gel loading solution (Sigma Chemical Co.) was supplied as a 5X 
solution of 0.05% (w/v) bromophenol blue, 40% (w/v) sucrose, 0.1 M 
EDTA (pH 8.0) and 0.5% (w/v) sodium dodecyl sulfate (SDS). It is 
suitable for non-denaturing agarose gel electrophoresis of nucleic acids. 
(13) Tris-Borate-EDTA (TBE) Electrophoresis Buffer 
90 mM Tris-borate and 2 mM EDTA, pH 8.0. 
(14) Standard Saline Citrate (SSC) (20X) 
Standard saline citrate (SSC) was prepared as a 20X stock solution of 3 
M NaCl and 0.3 M trisodium citrate. The pH was adjusted with NaOH to 
7.0. It was then sterilized by autoclaving and was stored at room 
temperature. 
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(15) Digoxigenin (DIG) Oligonucleotide 3,-End Labeling Kit 
The DIG oligonucleotide 3'-end labeling kit was purchased from 
Boehringer Mannheim and contained the following constituents: 
(i) 5X Reaction Buffer: 1 M potassium cacodylate, 0.125 M Tris-HCl, 1.25 
mgy'ml bovine serum albumin (BSA), pH 6.6 (25°C). 
(ii) Cobalt Chloride Solution: 25 mM cobalt chloride solution (C0Cl2). 
(iii) DIG-ll-ddUTP solution: 1 mM DIG-ll-ddUTP (Digoxigenin-3-0-
succinyl-s-aminocarproyl- [ 5 -(3 -aminoallyl)-2，,3 '-dideoxy-
uridine-5'-triphosphate] tetra lithium salt). 
(iv) Terminal Transferase: 50 units/^1 terminal transferase in 0.2 M 
potassium cacodylate, 1 mM EDTA, 200 mM KC1, 0.2 mg/ml 
BSA (pH 6.5’ 25°C), 50% (v/v) glycerol. 
(v) Glycogen Solution: 20 mgy^ ml glycogen solution. 
(16) Hybridization Buffer 
5X SSC，0.1% (w/v) blocking reagent (DIG Luminescent Detection 
Kit, Boehringer Mannheim), 0.1% (w/v) N-lauroyl-sarkosine (Sigma 
Chemical Co.) and 0.02% SDS. 
(17) Maleic Acid Buffer 
O.lM Maleic acid (Fluka Chemika), 0.15 MNaCl, pH 7.5. 
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(18) DIG Luminescent Detection Kit 
The DIG luminescent detection kit was purchased from Boehringer 
Mannheim and contained the following constituents: 
(i) Blocking Reagent 
(ii) CSPD®: Disodium 3-{4-methoxyspiro[l,2-dioxetane-3.2'-(5'-chloro) 
. tricyclo(3.3.1.1 )decan]-4-yl} phenyl phosphate. 
(iii) Anti-DIG-AP: 75 units/^1 alkaline phosphatase (AP) conjugated 
sheep anti-DIG polyclonal antibody (Fab fragment, IgM 
isotype) in 50 mM triethanolamine buffer, 3 mM NaCl, 1 mM 
MgCl2, 0.1 mM zinc chloride (ZnCl2) and 1% (w/v) BSA， 
pH 7.6. 
(19) Detection Buffer 
0.1 M Tris-HCl, 0.1 M NaCl, 50 mM MgCl2, pH 9.5. 
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2.2 METHODS 
2.2.1 Culture ofTumor Cell Lines 
The murine tumor cell lines (WEHI-3B JCS, Ml, PU5-1.8, P388D1, 
EAT, YAC-1 and MBL-2) were maintained as continuous suspension cultures 
in RPMI medium supplemented with 10% fetal calf serum and antibiotics (100 
units/ml penicillin G sodium, 100 ^g/ml streptomycin sulfate and 250 ngy'ml 
amphotericin B) (complete RPMI medium). The murine L929 and MH 3T3 
fibroblast cell lines were cultured in complete RPMI medium in 25 or 75 cm^ 
tissue culture flasks (Falcon) until the cells formed an almost confluent 
monolayer. The cells were then trypsinized (0.25% trypsin and 1 mM EDTA, 
GEBCO BRL Technologies) and washed three times with plain RPMI medium 
and then subcultoed in complete RPMI medium or used in the experiments. 
The human promyelocytic HL-60 cells were cultured in RPMI medium 
supplemented with 20% fetal calf serum and antibiotics. 
The cell lines were incubated at 37°C in a humidified incubator 
supplied with 5% carbon dioxide (CO2), and subcultured at 2-3 day intervals 
or twice weekly for murine and human cell lines, respectively. The tumor 
cells were maintained in exponential growth phase, and were not used beyond 
30 in vitro passages. Cryo-preservation in liquid nitrogen was used for long 
term storage of cell lines. 
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2.2.2 Determination of Cell Growth and Proliferation 
The cell growth of various tumor cell lines was determined after the 
addition of flavone and flavon-3-ol (3-hydroxyflavone) derivatives. The 
number of viable cells was determined by hemocytometer counting using the 
trypan blue dye exclusion method (McGahon et al., 1995). (Trypan blue dye 
solution, 0.4% (w/v) in PBS, Sigma Chemical Co.) 
Li addition, the MTT tetrazolium colorimetric assay was also employed 
as indicators of cell number and viability (Alley et al., 1988), since MTT 
(tetrazolium salt, 5 mgy^ ml in PBS) can be converted to a colored formazan 
derivatives via mitochondrial dehydrogenase activity by viable cells (Pagliacci 
et al., 1993). The dark blue formazan formed can be solubilized by DMSO 
and the absorbance of each well was measured at 570 nm using a ELISA 
micro-plate reader (BIO-RAD). Results were expressed as percentage of 
growth inhibition, using untreated cells as a control. 
The proliferative response of the flavonoid-treated tumor cells can be 
measured by [^-methyl-thymidine ([^H]-TdR) incorporation assay. Various 
tumor cell lines at indicated cell numbers were incubated with appropriately 
diluted flavonoid(s) in the wells of 96-well flat-bottomed microtitre plates at 
37°C for 48 hours in a fully humidified incubator containing 5% CO2. 
Cultures were then pulsed with 0.5 |uCi of [ ^ - T d R in 20 jul RPMI complete 
• 3 
medium ([ H]-TdR, specific activity of 2 Ci/mmole, Amersham International) 
from 8 to 16 hours. After one freeze and thaw cycle, they were then harvested 
onto the Whatman GF/C glass microfibre filter (Whatman Litemational Ltd.). 
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Radioactivity in counts per minute (cpm) was measured by the Beckman 
LS1801 liquid scintillation counter (Beckman Listruments Jnc.) Quadruplicate 
results were expressed as the percentage of [^H]-TdR incorporation, using 
untreated cells as control (Leung et al., 1994). 
2.2.3.Colony Assay 
Colony assay was performed by the method as described by Kobayashi 
et al. (1989). Briefly, semi-solid agar cell cultures were set up in the wells of 
leucocyte migration plate (Sterilin, Middlesex, U.K.). 0.4 ml cultures 
containing 0.33% Bacto agar (Difco, Detroit, MT), 200 untreated or flavone 
(0-50 ^M)-treated JCS cells, RPMI medium with 20% FCS, 2 mM glutamine 
and 60 units/ml gentamycin were incubated at 37°C for 7 days. The cell 
colonies were preserved by placing the agar discs onto the microscopic slides, 
dried and fixed with citrate-acetone-formaldehyde solution and stained with 
hematoxylin solution (Sigma Chemical Co.). Then colonies consisting more 
than 50 cells were counted (Mak et aL, 1993). 
2.2.4 In vivo Tumorigenicity Assay 
JCS cells (lxlO^ cells/ml) were incubated with flavone (0-50 |iM) for 
3 days at 37°C. The cells were washed three times with RPMI medium and 
lxlO^ viable cells were injected intraperitoneally into BALB/c mice in groups 
of five. Tumor cells were recovered fi:om the peritoneal cavity of mice and 
counted at day 14 post-tumor inoculation (Leung et al., 1994). 
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2.2.5 Induction ofLeukemic Cell Differentiation 
Li the differentiation induction experiment, the WEHI-3B JCS cells 
(lxl0Vml) were incubated with appropriately diluted flavone and 
3-hydroxyflavone in 96-well flat bottomed microtitre plate 0^'unc Lic.) or in 
^ 
25 cm tissue culture flasks (Coming Lic.) for 72 hours unless otherwise 
specified. 
2.2.6 Cell Morphological Study 
Cell morphology was examined on cytocentrifuge preparation of cells. 
Leukemia cells were induced to differentiate as described as Section 2.2.5. 
5xlO^ cells were centrifuged (500 rpm, 5 minutes) onto microscopic slides 
using Shandon Cytospin 3 centrifuge (Shandon Scientific Ltd.). Cells were 
then stained with modified Wright-Giemsa stain (Sigma Chemical Co.) for 
1 minute. They were rinsed in phosphate buffer (0.067 M KH2PO4 and 
Na2HPO4, pH 7.2)，followed by rinsing in a running water bath. The air-dried 
slides were mounted with the neutral mounting medium, Canada Balsam 
(Beijing Chemical Works). The number of cells at immature stage 
(myeloblasts and promyelocytes), intermediate stage (myelocytes and 
promonocyte-like cells) and mature stage (macrophage-like cells) were 
determined by differential counts under the microscopic observation. At least 
three hundred cells were scored on each slide and the results were expressed as 
mean 士 standard error (Mak et al,, 1993). 
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2.2.7 Assessment of Differentiation Associated Characteristics 
2.2.7.1 Nitroblue Tetrazolium (NBT) Reduction Assay 
Nitroblue tetrazolium dye reducing activity, which is a measurement 
for the amount of reactive oxygen species present in the cells, was assayed by 
a modification of the method described by Brietman (1990). 2xl0^ cells in 
100 fxl RPMI medium containing 20% ffl-FCS were incubated with an equal 
volume of 0.2% NBT in RPMI medium containing 1 p,g/ml of PMA. After 
incubation at 37°C for 3 hours in dark, the percentage of NBT-positive cells 
(cells containing intracellular blue-black deposits) was determined by counting 
at least three hundred cells on cytocentrifuge preparations, counter-stained 
with 1% safranin 0 (Sigma Chemical Co.) in methanol (Leung et aL, 1994). 
2.2.7.2 Assay of Plastic Adherence 
The percentage of the adherent cells in flavone-treated WEHI-3B JCS 
cells can be determined by hemocytometer counting using the trypan blue dye 
exclusion method (McGahon et al., 1995). To distinguish the non-adherent 
cells firom the adherent cells, the culture flask was shaken with warm PBS 
before harvest. The adherent cells remaining were then harvested by gently 
scraping with a cell scraper ^^unc Lic.). The experiment was performed in 
triplicate and the results were expressed as mean 土 standard error. 
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2.2.8 Flow Cytometric Analysis 
2.2.8.1 Surface Antigen Immunophenotyping 
Flow cytometric analysis was used for the immunophenotyping of the 
differentiating JCS cells. Cells harvested from 25 and 75 cm^ culture flasks 
were washed with the FACS washing buffer (PBS containing 2% HI-FCS and 
0.05% sodium azide) to inhibit the internalization of membrane components. 
The mouse IgG and rat IgG blocking antibodies (10 |igA:nl, Sigma Chemical 
Co.) were added to the JCS cells (2.5xl0^) at 4°C for 30 minutes to reduce the 
problem of Fc receptor binding and also the non-specific binding. They were 
then washed with FACS washing buffer once and incubated with 1 ^g 
monoclonal antibody or 50 pi hybridoma-derived antibody in a total volume of 
100 i^l at 4°C for 30 minutes. Unbound antibodies were removed by washing 
the cells three times with FACS washing buffer. Cells were stained in dark 
with 1 i^g FITC-conjugated goat anti-rat IgG antibody. After 30 minutes of 
incubation at 4°C, the cells were washed three more times with FACS washing 
buffer, and then fixed with paraformaldehyde (1% (w/v) in 0.85% NaCl, 
Sigma Chemical Co.) (Lanier and Wamer, 1981). 
The stained cells (lxlO^) were analyzed for forward scatter vs 90° 
scatter, as well as fluorescence intensity using the FACSort flow cytometer 
(Becton Dickinson Lmnunocytometry Systems) equipped with an argon laser 
set at an excitation wavelength of 488 nm. Data acquisition and data analysis 
were performed with the Lysys H software (Becton Dickinson 
tomunocytometry Systems) (Leung et aL, 1994). 
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2.2.8.2 Assay of Non-specific Esterase Activity 
Non-specific esterase activity was determined by the hydrolysis of 
fluorescein diacetate (FDA) (20 mg/ml stock solution in DMSO, Sigma 
Chemical Co.). After hydrolysis, the fluorescent and charged product, 
fluorescein, was entrapped inside the cells. Therefore, the enzymatic activity 
can be determined by analyzing the fluorescence intensity by flow cytometry 
(Darzynkiewicz et al., 1994). 
JCS cells (2xl0^) in RPMI medium containing 10% HI-FCS were 
incubated with 20 ^g/ml FDA in dark for 30 minutes at room temperature. 
The cells were washed three times with the FACS washing buffer and fixed 
with 1% paraformaldehyde. Fixed cells (lxlO^) were then analyzed for 
fluorescence intensity using the FACSort cytometry as described in Section 
2.2.8.1. 
2.2.8.3 Assay of Phagocytic Activity 
Phagocytic activity of the differentiating cells was determined by the 
uptake of FITC-conjugated latex (1.09xl0^ latex/ml, Polyscience Ltd.). JCS 
cells (lxlO^) in RPMI medium containing 10% HI-FCS were incubated with 
5xlO^ FITC-conjugated latex in a total volume of 0.5 ml in a siliconized 
12x96mm test tube. After 6 hours of incubation in dark, the cell-particle 
suspensions were carefully layer onto the top of 2 ml BSA (2% in RPMI 
medium (w/v), Sigma Chemical Co.), and centrifuged at 1000 rpm for 
10 minutes. The supernatant was aspirated and the cell pellet was washed 
three more times with plain RPMI medium. The former gradient washing 
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separated free latex particles from the cells as well as stripping the loosely 
adherent microspheres from the cells (Stewart et al., 1986). The 
paraformaldehyde-fixed cells were then analyzed for fluorescence intensity 
using the FACSort cytometer as described in Section 2.2.8.1. 
2.2.8.4 Assay ofEndocytic Activity 
Endocytic activity was determined by the uptake of FITC-conjugated 
bovine serum albumin (FITC-BSA). 0.1 ml FITC-BSA (1 mg/ml in RPMI 
medium containing 10% HI-FCS, Sigma Chemical Co.) was added to 0.9 ml 
ofJCS cells (5xl0^) in RPMI medium containing 10% HI-FCS. After 6 hours 
of incubation at 37°C at dark, the cell mixture was washed three times with 
plain RPMI medium and then fixed with 1% paraformaldehyde. Fixed cells 
(lxl04) were then analyzed for fluorescence intensity using the FACSort 
cytometer as described in Section 2.2.8.1. 
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2.2.8.5 Cell CycleyT>NA Content Evaluation 
Flow cytometric analysis of cellular DNA content, cell cycle frequency 
distributions and chromosome profiles of differentiating cell populations were 
performed according to the method described by Crissman and Hirons (1994). 
JCS cells (lxlO^) were harvested from culture flask, and washed once with 
PBS. The cells were then fixed with 1 ml of 70% ethanol for 30 minutes at 
4°C，and the fixed cells were washed with PBS twice to remove as much 
ethanol as possible. Afterwards, the washed cells were stained with 1 ml of 
propidium iodide DNA staining solution in dark for 1.5 hours at room 
temperature. 
Stained cells (lxlO^) were analyzed immediately for fluorescence 
intensity using the FACSort flow cytometer as described in Section 2.2.8.1. 
Data acquisition was performed with the Lysys H software, then the 
calculation of cell cycle distribution was performed with the CellFIT program 
using the rectangle fit (RFIT) analysis model (Becton Dickinson 
knmunocytometry Systems) (Brons et al., 1994). 
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2.2.9 Gene Expression Analysis 
2.2.9.1 Cell Lysate Preparation 
Cell lysates were prepared using the guanidine thiocyanate lysis buffer 
(Chirgwin et al., 1979). JCS cells (lxlO^) were cultured with flavone (50 ^M) 
or its solvent (0.05% ethanol) at 37°C in 150 cm^ culture flask for different 
periads oftime (8，18 and 48 hours) and untreated JCS cells (lxlO^) were also 
included as the control sample. At different periods of time, the cells were 
harvested by gentle shaking with plain RPMI medium. After centrifugation, 
the supernatant was decanted and the cell pellet was resuspended by strong 
vortexing. The cell suspension was added dropwise to 4 M guanidine 
thiocyanate with continuous vortexing to obtain a homogeneous cell lysate. 
The cell lysates were stored at -70°C until use. 
2.2.9.2 Total RNA Isolation by Cesium Chloride Isopycnic Gradient 
The fi:ozen cell lysates were recovered in a 65°C water bath with 
constant vortexing to shear the DNA molecule until it was completely thawed. 
The thawed cell lysates were chilled on ice immediately after incubating for 
5 minutes in a 65°C water bath. The cell lysates were layered onto sterile, 
DEPC-treated polyallomer ultra-centrifuge tubes (Beckman Listruments Lic.) 
containing a cushion of 1.5 ml of 5.7 M cesium chloride (Sigma Chemical 
Co.), and centrifuged with the Beckman ultra-centrifuge (Beckman 
Instruments Lic.) fitted with the SW55Ti rotor at 35,000 rpm for 18 hours at 
18°C. 
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The overlaying solution at the top (1 cm from the pellet) was removed 
by aspiration, and the tube was quickly inverted and remained at its inverted 
position to drain out the remaining liquid, and it was aspirated dry without 
disturbing the clear RNA pellet. Then the bottom 0.5 cm ofthe tube, which 
containing the clear RNA pellet, was cut off with a sterile scalpel blade. The 
RNA pellet was rinsed with a total volume of 400 i^l sterile DEPC-treated 
water. The RNA was precipitated with the addition of 1 ml absolute ethanol 
and 45 }il 3 M sodium acetate (Sigma Chemical Co.). The mixture was 
washed with 70% ethanol and then with absolute ethanol. After being dried in 
a speed vacuum concentrator (Savant 110 Speed-Vac®), the resulting pellet 
was resuspended in 50 i^l DEPC-treated water and stored at -70°C for future 
use. The amount ofRNA was estimated by spectrophotometry at 260 nm UV 
light. An optical density of 1 unit corresponds to 40 i^g RNA and optical 
density at 280 nm was also measured to estimate the purity ofthe RNA sample 
(Maniatis et aL, 1982). 
2.2.9.3 Reverse Transcription 
1 昭 of total cellular RNA was incubated at 65°C for 5 minutes and 
reverse-transcribed at 3TC for 1 hour by adding a mixture containing 40 units 
rRNasin, 10 mM dithiothreitol (DTT), 0.5 mM of each dNTP, 0.1 昭 oligo-
dTi2-i8, IX first strand buffer and 200 units ofMoloney murine leukemia virus 
(MMLV) reverse transcriptase. The reaction was terminated by chilling on 
ice, and the resulting cDNA samples were stored at -20°C until use (Fung et 
al., 1992). 
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2.2.9.4 Polymerase Chain Reaction (PCR) 
The cDNA samples were boiled for 5 minutes followed by chilling on 
ice immediately. 0.1 [ig (2 i^l) of the pre-boiled cDNA samples were 
amplified in a 60 |il reaction mixture containing 0.2 mM of each dNTP, 
1 pmole/^il of each oligonucleotide primer, 1.5 mM MgCl2 (Advanced 
Biotechnologies, Ltd.), IX reaction buffer and 0.6 unit of the Thermoprime^^"' 
DNA polymerase, and was overlaid with mineral oil (Sigma Chemical Co.). 
The reaction mixture was subjected to certain rounds of temperature 
cycling with PTC-100™ Programmable Thermal Cycler (MJ Research, USA). 
The initial denaturation at 94°C for 5 minutes was included in the first cycle. 
The thermal cycle profile was as follow: denaturation at 94°C for 1 minute, 
annealing for 1 minute at a temperature optimized for each pair of primers 
(melting temperature [Tm]-10°C) (Table 2.3). The number of cycles was also 
empirically optimized for each primer set (Table 2.3). The amplified samples 
were stored at -20°C until use. 
The amount of RNA used in PCR amplification was normalized by 
comparing with the amplification of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) mRNA for 20 cycles. Moreover, the negative 
control without the cDNA template was included to check for the presence of 
any contaminants. The false negative was also ruled out by including the 
cDNA sample prepared from mouse spleen cells stimulated with concanavalin 
A (Con A). All analyses were performed at least twice independently (Mak et 
al., 1993). 
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Table 2.3: The cycling profile used in RT-PCR study. 
Gene ~~Annealing Temperature ("C)~~ Number ofCycles 
GAPDH 52 20 
~ T N F ^ ^ 257^ 
~~M-CSF 56 20,25,30 
E 5 ^ 40 
~~BL-la 56 40 
£16 56 40 
2.2.9.5 Agarose Gel Electrophoresis 
After incubating the PCR reaction products at 37°C water bath for 
5 minutes, 20 ^1 ofthe PCR reaction product was loaded together with IX gel 
loading buffer and was subjected to electrophoresis in IX TBE electrophoresis 
buffer on 2% agarose gel (Sigma Chemical Co.) at a constant voltage of 
5 volts/cm for 3-4 hours. 1 i^g of 1 kb DNA ladder (GEBCO BRL Life 
Technologies Lic.) was loaded as size marker. Then the gel was stained with 
0.5 i^gAnl ethidium bromide (Sigma Chemical Co.) in IX TBE buffer for 
30 minutes and destained in distilled water for 15 minutes. The stained gel 
was visualized under short-wavelength ultraviolet illumination and 
photographed with red filter using the Polaroid Type 667 instant pack film. 
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2.2.9.6 DIG 3，End Labeling ofOligonucleotide Probes 
Oligonucleotide probes ranging from 16-22 nucleotides in length was 
end-labeled with digoxigenin-11-ddUTP using the DIG oligonucleotide 3'-end 
labeling kit according to the standard protocol provided by the manufacturer 
(Boehringer Mannheim). For each probe, a 20 fil reaction mixture containing 
100 pmoles oligonucleotide probe, IX reaction buffer, 5 mM C0Cl2, 50 i^M 
DIG-ll-ddUTP and 50 units terminal transferase was incubated at 37°C for 
15 minutes and then placed on ice. 2 ^1 of glycogen (0.1 jLig/pl in 0.2 mM 
EDTA, pH 8.0) was added to stop the reaction. The labeled oligonucleotides 
were precipitated by 2.5 ^1 of 4 M lithium chloride solution (Sigma Chemical 
Co.) and 75 ^1 of pre-chilled (—20�C) absolute ethanol, and the mixture was 
kept at —20�C for 2 hours. After centrifugation, the pellet was washed with 
70% cold ethanol and vacuum-dried with Savant SC110 Speed-Vac®. The 
pellet was resuspended in 50 i^l ofDEPC-treated water and stored at -20�C for 
future use fVan Miltenburg et aL, 1995). 
2.2.9.7 Dot Blot Hybridization 
The PCR products (15 i^l) were immobilized on positively charged 
nylon membrane (Boehringer Mannheim 1209299) using the Bio-Dot® 
microfiltration apparatus (Bio-Rad Laboratories). The PCR products were 
denatured in a total volume of200 i^l of 0.2 M NaOH for 15 minutes at room 
temperature before they were applied to the pre-wetted nylon membrane. 
Then the membrane was neutralized by washing two times with 400 ^1 of 20X 
SSC. The blotted membrane was then baked at 120°C for 30 minutes to 
crosslink the DNA and stored at room temperature for future use. Nylon 
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membranes containing the immobilized PCR products were placed in 50 ml 
centrifuge tubes (Falcon) containing the pre-hybridization solution pre-
warmed to the hybridization temperature (56°C) which was 10°C below the 
melting temperature of the probe. The membranes were then incubated in a 
hybridization chamber for 4 hours. Afterwards, the membrane was hybridized 
with the labeled probe by incubating with the hybridization buffer containing 
4 pmole/ml DIG-labeled oligonucleotide probe at the hybridization 
temperature for 12 hours. The membranes were washed twice with 25 ml of 
2X SSC, 0.1% (w/v) SDS, followed by 0.5X SSC, 0.1% (w/v) SDS for 
5 minutes at the hybridization temperature. The blot was then used for 
immunological chemiluminescent detection with CSPD® (Holtke et aL, 
1992). 
2.2.9.8 DIG Chemiluminescent Detection 
Chemiluminescent detection ofthe DIG-labeled hybrids was performed 
by using the DIG luminescent detection kit (Boehringer Mannheim). The 
nylon membrane was rinsed for 5 minutes in washing buffer (maleic buffer 
containing 0.3% (v/v) Tween®20) (Bio-Rad Laboratories). The membrane 
was first incubated with blocking solution (1% in maleic acid buffer, w/v) for 
30 minutes, followed by diluted anti-DIG-AP conjugate (0.075 units/ml) for 
another 30 minutes with constant mixing at room temperature. Unbound 
antibodies were removed by washing the membrane with washing buffer 
twice, 5 minutes per wash. 
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Then the membrane was equilibrated with detection buffer for 
5 minutes and then incubated with freshly prepared CSPD® substrate solution 
(100 X dilution in detection buffer) for 5 minutes at room temperature. The 
wet membrane was wrapped in Saranwrap and luminescent reaction was 
enhanced by incubating it at 37°C for 15 minutes. The sealed membrane was 
exposed to Kodak X-Omat™ AR X-ray film (Kodak Scientific Lnaging Film) 
for 5-10 minutes. Exposed film was then developed using the Kodak RP 
X-OMAT developer repleniser and Kodak GBX fixer repleniser (Kodak 
Scientific Lmaging Film). X-ray film was then analyzed for the hybridization 
signal using the PC version ofbiage QuaNT (Molecular Dynamics) software 
in a laser densitometer (Personal Densitometer SI, Molecular Dynamics). 
2.2.10 DNA Fragmentation Analysis 
The apoptotic DNA fragments were isolated using the NP-40 lysis 
method (Herrmann et al., 1994). JCS cells (lxlO^) were incubated with 
flavone (50 pM) in 150 cm^ culture flask at 2>TC for different periods of time 
(2，8’ 12, and 24 hours) and the untreated JCS cells (lxlO^) were acted as the 
control. The harvested cells were washed with PBS and centrifuged. The cell 
pellet was then treated with NP-40 lysis buffer for 5 minutes at 37°C. After 
centrifugation at 3500 rpm for 5 minutes with the ffiC MicroMax Eppendorf 
centrifuge, the supernatant was transferred to a new Eppendorf tube. Then 
1% SDS was added and treated with 0.4 |dg/fdl RNase A at 56�C for 1.5 hours, 
and followed by the digestion with 1.5 [ig/[xl proteinase K (Sigma Chemical 
Co.) at 56°C for further 1.5 hours. Then 2.5 volume of absolute ethanol and 
0.1 volume of 3 M sodium acetate (Sigma Chemical Co.) were added to 
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precipitate the DNA. After centrifugation, the DNA pellet was washed with 
ethanol and vacuum-dried as described in Section 2.2.9.2. The pellet was 
resuspended in 20 |il TioEo.i buffer and the samples were incubated at 65°C for 
5 minutes. Then gel electrophoresis was performed as described in Section 
2.2.9.5 using 100 bp DNA ladder (GffiCO BRL Life Technologies Lic.) as size 
marker. 
2.2.11 Statistical Analysis 
Each experiment was performed at least twice, and the representative 
results from one experiment were presented. The results were expressed as 
mean 土 standard error. The Student's t-test was used for statistical analysis. 
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3.1 INTRODUCTION 
Flavonoids are a group of naturally occurring low molecular weight 
phenolic compounds commonly found in a wide variety of plants, including 
the most common fruits and vegetables (Boik, 1996). The basic structure of 
flavonoid consists of two benzene rings linked up by a C3 pyrone group, at 
which different chemical groups attached characterized the types of flavonoid. 
Flavonoids appear to be the active constituents found in many medicinal 
plants, and they are widely used in traditional medicine and as food 
supplements. Recent researches have shown that flavonoids exhibit diverse 
biological effects, including anti-allergic, anti-inflammatory, 
immunomodulatory, anti-viral and anti-tumoral activities (Boik, 1996 and 
Middleton, 1996). Although the importance of flavonoids is becoming more 
prominent when their anti-oxidant and anti-carcinogenic mechanisms are 
unraveled (Hollman et aL, 1995; Korkina and Afanas, 1996)， yet their 
therapeutic potentials have not been fully explored. 
Flavones and flavonols, which are the most widely occurring 
flavonoids, have been shown to possess anti-proliferative effect on a variety of 
leukemic cell lines such as HL-60, K562 and MOLT-4 (Larocca et aL, 1991; 
Hirano et al., 1994 and Csokay et al., 1997). Moreover, the ability of the 
leukemia cells to form colonies in soft agar and their RNA, DNA and protein 
syntheses were also inhibited (Hirano et al., 1994 and Csokay et aL, 1997). 
Although there is increasing evidence showing that flavonoids can display 
profound effects on the proliferation of a variety of tumor cell lines in vitro 
(Middleton, 1996)，but the precise mechanisms responsible for the anti-tumor 
effect of flavonoids are not completely understood. 
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We have previously shown that the murine myelomonocytic WEHI-3B 
JCS cell line is a good model for studying leukemia cell growth and 
differentiation. The growth of leukemia cells was inhibited and they could 
readily undergo monocytic differentiation in response to a variety of cytokines 
and differentiation inducing agents, such as TNF-a, IL-la and EL-lp (Mak et 
aL, 1993 and Chan et aL, 1997), phorbol-12-myristate 13-acetate (PMA) and 
lipopolysaccharide (LPS) (Mak et aL, 1993 and Chan et al., 1995). 
t i this chapter, the effects of different flavonoids on the proliferation 
and apoptosis of the murine myeloid leukemia WEHI-3B JCS cells were 
examined. Attempts had been made to compare the anti-proliferative effect of 
flavonoids on different tumor cell lines. Finally, the effects of flavone on the 
clonogenicity of the leukemia JCS cells in vitro and tumorigenicity in vivo 
were also studied. 
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3.2 RESULTS 
3.2.1 Growth-Inhibitory Effects of Flavone on Murine Myeloid Leukemia 
JCS Cells 
JCS cells were incubated with different concentrations of flavone (0-
200 ^M) for 48 hours, and the cell proliferation rate was determined by 
tritiated thymidine incorporation assay. Results in Figure 3.1 show that flavone 
inhibited the proliferation of JCS cells in a dose-dependent manner. Half-
maximal inhibition was observed at a concentration of about 25 p.M, whereas 
maximum anti-proliferative activity was obtained with 50 i^M flavone, and the 
growth-inhibitory activity of flavone was not increased further at higher 
concentrations of flavone. As a result, with the reference to its anti-
proliferative activity on JCS cells, the sub-optimal and optimal dose of flavone 
used in subsequent experiments were determined to be 25 ^M and 50 |iM 
respectively. Li parallel with the thymidine incorporation assay, the effect of 
flavone on the growth of JCS cell was also determined by viable cell counting 
using the trypan blue exclusion assay. Li consistent with the thymidine 
incorporation assay, a parallel reduction of viable cell number was observed 
(Table3.1). 
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Figure 3.1: Inhibitory effect offlavone on the proliferation ofJCS cells. WEHI-3B 
JCS cells (2xl0^ cells / 200 i^l) were incubated with different concentrations of 
flavone (0-200 juM) at 37°C for 48 hours. Cultures were then pulsed with 0.5 ^Ci of 
^H-TdR for 8 hours before harvest. Radioactivity in counts per minute (cpm) was 
measured using scintillation counting. Results were expressed as % inhibition of ^ H-
TdR incorporation, using the untreated JCS cells as control. Each point represents the 
mean 土 standard error of quadruplicate wells. The x-axis was plotted in a logarithmic 
scale. 
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Table 3.1 : Growth-inhibitory effect of flavone on JCS cells. 
Concentration of flavone (^M) % Inhibition (mean 土 standard error) 
Control -
1 ^ 24.5±1.50 
^ 45.3±2.56 
^ 90.7士3.86 
JCS cells (lxlO^ cells/ml) were incubated with different concentrations (0-200 |iM) 
of flavone at 37°C for 48 hours. The number of viable cells was counted using the 
trypan blue exclusion assay. Results from triplicate experiments were expressed as 
% inhibition of cell growth, using untreated JCS cells as control. 
The anti-proliferative effect of flavone on JCS cells was also 
determined by the microculture tetrazolium colorimetric assay (MTT reduction 
assay) which is commonly employed as indicators of cell number and viability. 
Since MTT can be converted to a dark blue formazan derivative via 
mitochondrial hydrogenase present in the viable cells, the amount of dark-blue 
formazan formed can be evaluated by measuring the absorbance at 540 nm. 
Figure 3.2 shows that flavone caused a dose-dependent decrease in absorbance 
measured at 540 nm, the results from MTT assay were found to be in parallel 
with those obtained from the thymidine incorporation and trypan blue 
exclusion assay. 
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Figure 3.2: Effect of flavone on the proliferation of JCS Cells as measured by 
MTT Reduction Assay. WEffl-3B JCS cells (2xl0^ cells / 200 ^1) were incubated 
with different concentrations of flavone (0-200 i^M) at 37°C for 48 hours. Cultures 
were taken out at different periods of time (8, 24 and 48 hours). 10 i^l MTT (5 
mgAnl in PBS) was added to the cultures and incubated for 4 hours. The blue 
formazan formed was solubilized with DMSO. The absorbance was measured at 540 
run. Results were expressed as % decrease in absorbance measured at 540 nm, using 
untreated JCS cells as control. Each point represents the mean 土 standard error of 
quadruplicate wells. The x-axis was plotted in a logarithmic scale. 
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3.2.2 Cytotoxic Effects of Flavone on Murine Lymphocytes and Myeloid 
Leukemia JCS Cells 
Different concentrations of flavone (0-100 i^M) were tested for their 
cytotoxic effect on leukemia JCS cells (lxlO^ cells/ml) and lymphocytes from 
BALB/c mice (2.5xl0^ cells/ml). Cytotoxicity was determined by the trypan 
blue exclusion assay measured at different time courses (0, 8, 24 and 48 
hours). As shown in Figure 3.3 and 3.4，both the optimal and sub-optimal 
concentrations of flavone (25 i^M and 50 ^M respectively) did not exhibit any 
significant cytotoxic activity on leukemia JCS cells and normal murine 
lymphocytes. However, significant cytotoxicity was observed at a higher 
concentration (100 p,M) of flavone ( � 3 5 % and 15% increase in dead cell 
numbers at 48 hours for leukemia JCS cells and normal lymphocytes 
respectively). 
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Figure 3.3: Effect of Flavone on the viability of JCS cells using trypan blue 
exclusion assay. WEHI-3B JCS cells (lxlO^ cells / lml) were incubated with 
different concentrations of flavone (0-100 jiM) at 37�C for 48 hours. Cultures were 
taken out at different periods oftime (8，24 and 48 hours). After staining with trypan 
blue solution (0.5 % w/v) the nimiber of cells was counted under light microscopy. 
Results were expressed as % dead cells, which appeared as blue, when compared with 
total cell number in each treatment. The x-axis was plotted in a logarithmic scale. 
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Figure 3.4: Effect of flavone on viability of lymphocyte of BALB/c mice 
measured by trypan blue exclusion assay. BALB/c lymphocytes (5xlO^ cells / 200 
^1) were incubated with different concentrations of flavone (0-100 i^M) at 37°C for 
48 hours. Cultures were taken out at different periods of time (8, 24 and 48 hours). 
After staining with trypan blue solution (0.5 % w/v) the number of cells was counted 
under light microscopy. Results were expressed as % dead cells, which appeared as 
blue, when compared with total cell number in each treatment. The x-axis was plotted 
in a logarithmic scale. 
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3.2.3 Effects ofDifferent Flavonoids on the Proliferation ofLeukemia JCS 
Cells 
Jn view of the potent anti-proliferative activity of flavone on the murine 
myeloid leukemia JCS cells (Figure 3.1), it is of great interest to examine the 
effects of different flavonoids on the proliferation of JCS cells. Different 
derivatives of flavone (3-hydroxyflavone, 6-hydroxyflavone, 7-hydroxy 
flavdne and chrysin) as well as flavonol (galangin, fisetin, quercetin, morin 
hydrate and myricetin) were included in the present study. As shown in 
Figure 3.5 and 3.6，JCS cells exhibited differential sensitivities to different 
flavone and flavonol derivatives, with IC50 ranged from 10 to 200 |iM (Table 
3.2). It was found that flavonol (3-hydroxyflavone) displayed the most potent 
cytostatic effect on JCS cells (IC50 = � 1 0 |iM), followed by myricetin 
(IC50 = ~17 |iM), flavone and 6-hydroxyflavone (IC50 = -25 [xM), whereas 
morin hydrate had only weak cytostatic activity towards JCS cells 
(IC50 二 � 2 0 0 pM) 
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Figure 3.5: Inhibitory effect of flavone and its derivatives (3-OH flavone, 6-OH 
flavone, 7-OH flavone and chrysin) on the proliferation of JCS cells. WEHI-3B 
JCS cells (2xl0^ cells / 200 i^l) were incubated with different concentrations of 
flavonoids (0-200 piM) at 37°C for 48 hours. The cultures were then pulsed with 0.5 
^Ci of3H-TdR for 8 hours before harvest. Radioactivity in counts per minute (cpm) 
was measured using scintillation counting. Results were expressed as % inhibition of 
^-TdR incorporation, using the untreated JCS cells as control. Each point represents 
the mean 士 standard error of quadruplicate wells. The x-axis was plotted in a 
logarithmic scale. 
； 7 ] 
‘ - • Ch. 3 Regulation on Growth & Survival 
120 ^ — 
• Flavonol 
9 . « « - M - Galangin • 血 血 • 
•I 1 0 0 - _^Fisetin P ~ ^ V / ^ ^ 
h ~ ^ - Quercetin / 疋 Z / 
On on - • • Morin Hydrate / . f / 
0 _ " • “ Myricetin / 1 ^ / / 
1 6 � - / / / / J 
^ 4 0 - /y^/ 
1 , 0 A/'^y , : ' 
！ : : ^ . i . / 
一20 I 1 I__I I I I I 丨 1 1—1~I ' I ' ' I “ ~ 
0 10 100 
Concentration of Flavonoid ( _ ) 
Figure 3.6: Inhibitory effect of flavonol and its derivatives (galangin, fisetin, 
quercetin, morin hydrate and myricetin) on the proliferation of JCS ceUs. 
WEHI-3B JCS cells (2xl0^ cells / 200 ^1) were incubated with different 
concentrations of flavonoids (0-200 ^M) at 37�C for 48 hours. The cultures were 
then pulsed with 0.5 ^iCi of ^ - T d R for 8 hours before harvest. Radioactivity in 
counts per minute (cpm) was measured using scintillation counting. Results were 
expressed as % inhibition of ^ - T d R incorporation, using the untreated JCS cells as 
control. Each point represents the mean 士 standard error of quadruplicate wells. The 
X-axis was plotted in a logarithmic scale. 
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Table 3.2: The Estimated IC50 values of flavone and flavonol derivatives on JCS 
and Ml cells. 
Flavonoids ~~IC50 for myeloid leukemia WEHI-3B JCS cells 
( 幽 
Flavone 25 
6-OH Flavone — 25 







Morin Hydrate ^ 
Myricetin 17 
JCS cells (lxlC)4 cells/ml) were incubated with different concentrations of flavone 丨 
and flavonol derivatives (0-200 i^M). The cultures were then pulsed with 0.5 U^^ i of 
^-TdR for 8 hours before harvest. Radioactivity in counts per minute (cpm) was 
measured using scintillation counting. Results were expressed as % inhibition of ^ H-
TdR incorporation, using the untreated JCS cells as control. IC50 value was estimated 
as the concentration of flavonoid, in which 50% inhibition of ^-TdR incorporation 
was found. 
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3.2.4 Anti-proliferative Effect of Flavonoids on Different Tumor Cell 
Lines 
Since flavone and flavonol exhibited the most potent cytostatic activity 
on the myeloid leukemia JCS cells, therefore, their anti-proliferative activities 
on other tumor cell lines were also evaluated. The tumor cell lines studied 
include myeloid leukemia cell lines (Ml and HL-60) (Figure 3.7)， 
macrophage-like cell lines, (PU5-1.8 and P388D1) (Figure 3.8)，fibroblast cell 
lines (L929 and MH3T3) (Figure 3.9), a carcinoma cell line (EAT) (Figure 
3.10) and T lymphoma cell lines (MBL-2 and YAC-1) (Figure 3.11) and their 
anti-proliferative effects were compared to that of JCS cells. As shown in ！ 
1 
Table 3.3，all the cell lines tested were sensitive to the cytostatic effect of | 
i 1 
flavone, with IC50 ranged fi:om 25-55 ^M and the maximal inhibition of cell ！ 
i 
I 
proliferation occurred at a concentration of 50-100 ^M. On the other hand, ', 
• 1 
flavonol exhibited more potent cytostatic activity on the panel of tumor cell 
I 
lines tested, with IC50 ranged from 12-25 ^M. 
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Figure 3.7a: Inhibitory effect offlavone on the proliferation of myeloid leukemia 
cells (JCS, Ml and HL-60 ceUs). JCS cells (2xl0^ cells / 200 ^1), Ml cells (5xlO^ 
cells / 200 i^l) and HL-60 cells (lxlO^ cells / 200 1^) were incubated with different 
concentrations of flavone (0-200 i^M) at 37°C for 48 hours. Cultures were then 
pulsed with 0.5 ^Ci of ^H-TdR for 8 hours before harvest. Radioactivity in counts 
per minute (cpm) was measured using scintillation counting. Results were expressed 
as % inhibition of^-TdR incorporation, using the untreated JCS, Ml or HL-60 cells 
as control. Each point represents the mean 士 standard error of quadruplicate wells. 
The x-axis was plotted in a logarithmic scale. 
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Figure 3.7b: Inhibitory effect of 3-hydroxyflavone on the proUferation of myeloid 
leukemia cells (JCS, Ml and HL-60 cells). JCS cells (2xl0^ cells / 200 j_d)，Ml 
cells (5xl0^ cells / 200 i^l) and HL-60 cells (lxlO^ cells / 200 i^l) were incubated with 
different concentrations of3-OH flavone (0-100 i^M) at 37°C for 48 hours. Cultures 
were then pulsed with 0.5 i^Ci o f ^ T d R for 8 hours before harvest. Radioactivity in 
counts per minute (cpm) was measured using scintillation counting. Results were 
expressed as % inhibition of ^-TdR incorporation, using the untreated JCS, Ml or 
HL-60 cells as control. Each point represents the mean 土 standard error of 
quadruplicate wells. The x-axis was plotted in a logarithmic scale. 
76 
‘ - • Ch. 3 Regulation on Growth & Survival 
120 j -
0 - • - JCS ^ _ 
1 1 0 0 - + P U 5 _ 1 . 8 9 - ^ 1 ^ ^ 
I - ^ P388D1 T / 
i ： / �-J 
Q j 1 ^ ^ - " - r - - r W , I I j 1 _ j _ I I I I I I I L _ J 
0 10 100 
Concentration of Flavone (pM) 
Figure 3.8a: Inhibitory effect offlavone on the proliferation of myeloid leukemia 
JCS cells and macrophage-like tumors gPU5-1.8 and P388D1 cells). JCS cells 
(2xl0^ cells / 200 i^l), PU5-1.8 cells (lxlO^ cells / 200 i^l) and P388D1 cells (lxlO' 
cells / 200 i^l) were incubated with different concentrations offlavone (0-200 i^M) at 
37°C for 48 hours. Cultures were then pulsed with 0.5 ^Ci of ^H-TdR for 8 hours 
before harvest. Radioactivity in counts per minute (cpm) was measured using 
scintillation counting. Results were expressed as % inhibition of 3H-IdR 
incorporation, using the untreated JCS, PU5-1.8 or P388D1 cells as control. Each 
point represents the mean 士 standard error of quadruplicate wells. The x-axis was 
plotted in a logarithmic scale. 
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Figure 3.8b: Inhibitory effect of 3-hydroxyflavone on the proUferation of myeloid 
leukemia JCS cells and macrophage-like tumors OPU5-1.8 and P388D1 cells). 
JCS cells (2xl0^ cells / 200 ^1), PU5-1.8 cells (lxlO^ cells / 200 i^l) and P388D1 cells 
(lxl04 cells / 200 i^l) were incubated with different concentrations of 3-OH flavone 
(0-100 i^M) at 37°C for 48 hours. Cultures were then pulsed with 0.5 piCi of^-TdR 
for 8 hours before harvest. Radioactivity in counts per minute (cpm) was measured 
using scintillation counting. Results were expressed as % inhibition of ^H-TdR 
incorporation, using the untreated JCS, PU5-1.8 or P388D1 cells as control. Each 
point represents the mean 土 standard error of quadruplicate wells. The x-axis was 
plotted in a logarithmic scale. 
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Figure 3.9a: Inhibitory effect of flavone on the proliferation of myeloid leukemia 
JCS cells and fibroblast tumors 0Vffl3T3 and L929 cells). JCS cells (2xl0' cells / 
200 |al), MH3T3 cells (5xlO^ cells / 200 1^) and L929 cells (5xlO^ cells / 200 i^l) 
were incubated with different concentrations of flavone (0-200 ^M) at 37°C for 48 
hours. Cultures were then pulsed with 0.5 fiCi of ^-TdR for 8 hours before harvest. 
Radioactivity in counts per minute (cpm) was measured using scintillation counting. 
Results were expressed as % inhibition of ^ - T d R incorporation, using the untreated 
JCS, NM3T3 or L929 ceUs as control. Each point represents the mean 土 standard 
error of quadruplicate wells. The x-axis was plotted in a logarithmic scale. 
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Figure 3.9b: Inhibitory effect of3-hydroxyflavone on the proUferation ofmyeloid 
leukemia JCS cells and fibroblast tumors OVffl3T3 and L929 ceUs). JCS cells 
(2xl0^ cells / 200 � , N f f i 3 T 3 cells (5xlO^ cells / 200 i^l) and L929 cells (5xlO^ cells 
/ 200 |il) were incubated with different concentrations of 3-OH flavone (0-100 fiM) 
at 37�C for 48 hours. Cultures were then pulsed with 0.5 i^Ci of ^-TdR for 8 hours 
before harvest. Radioactivity in counts per minute (cpm) was measured using 
scintillation counting. Results were expressed as % inhibition of ^-TdR 
incorporation, using the untreated JCS, Nffl3T3 or L929 cells as control. Each point 
represents the mean 士 standard error of quadruplicate wells. The x-axis was plotted in 
a logarithmic scale. 
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Figure 3.10a: Inhibitory effect offlavone on the proliferation ofmyeloid leukemia 
JCS cells and carcinoma EAT cells. JCS cells (2xl0^ cells / 200 ^il) and EAT cells 
(5xlO^ cells / 200 ]al) were incubated with different concentrations offlavone (0-200 
^M) at 37°C for 48 hours. Cultures were then pulsed with 0.5 fiCi of ^H-TdR for 8 
hours before harvest. Radioactivity in counts per minute (cpm) was measured using 
scintillation counting. Results were expressed as % inhibition of ^H-TdR 
incorporation, using the untreated JCS or EAT cells as control. Each point represents 
the mean 士 standard error of quadruplicate wells. The x-axis was plotted in a 
logarithmic scale. 
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Figure 3.10b: Inhibitory effect of 3-hydroxyflavone on the proliferation of 
myeloid leukemia JCS cells and carcinoma EAT cells. JCS cells (2xl0^ cells / 200 
ial) and EAT cells (5xlO^ cells / 200 i^l) were incubated with different concentrations 
of 3-OH flavone (0-100 i^M) at 37°C for 48 hours. Cultures were then pulsed with 
0.5 ^Ci of 3H-TdR for 8 hours before harvest. Radioactivity in counts per minute 
(cpm) was measured using scintillation counting. Results were expressed as % 
inhibition of^H-TdR incorporation, using the untreated JCS or EAT cells as control. 
Each point represents the mean 土 standard error of quadruplicate wells. The x-axis 
was plotted in a logarithmic scale. 
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Figure 3.11a: Inhibitory effect offlavone on the proliferation ofmyeloid leukemia 
JCS ceUs and T lymphoma OVEBL-2 and YAC-1 cells). JCS cells (2xl0^ cells / 200 
i^l), MBL-2 cells (5xlO^ cells / 200 i^l) and YAC-1 cells (5xl0^ cells / 200 1^) were 
incubated with different concentrations offlavone (0-200 ^M) at 37°C for 48 hours. 
Cultures were then pulsed with 0.5 i^Ci of ^I-TdR for 8 hours before harvest. 
Radioactivity in counts per minute (cpm) was measured using scintillation counting. 
Results were expressed as % inhibition of ^H-TdR incorporation, using the untreated 
JCS, MBL-2 or YAC-1 cells as control. Each point represents the mean 土 standard 
error of quadruplicate wells. The x-axis was plotted in a logarithmic scale. 
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Figure 3.11b: Inhibitory effect of 3-hydroxyflavone on the proliferation of 
myeloid leukemia JCS cells and T lymphoma OVffiL-2 and YAC-1 cells). JCS 
cells (2xl0^ cells / 200 i^l), MBL-2 cells (5xl0^ cells / 200 i^l) and YAC-1 cells 
(5xlO^ cells / 200 1^) were incubated with different concentrations of 3-OH flavone 
(0-100 i^M) at 37�C for 48 hours. Cultures were then pulsed with 0.5 i^Ci of^-TdR 
for 8 hours before harvest. Radioactivity in counts per minute (cpm) was measured 
using scintillation counting. Results were expressed as % inhibition of 3H-TdR 
incorporation, using the untreated JCS, MBL-2 or YAC-1 cells as control. Each point 
represents the mean 土 standard error of quadruplicate wells. The x-axis was plotted in 
a logarithmic scale. 
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Table 3.3: The IC50 values of flavone and 3-hydroxyflavone on different tumor 
cell Unes. 
Flavone 3-OH Flavone 
IC50 Optimal IC50 Optimal 
Cell Line Value Concentration t Value Concentration J 
(^ M)卞 （ i^M) (liM) t (\m 
WEHI-3B JCS ^ 50 U ^ 
m 25 50 u ^ 
HL-60 45 r ^ ^ r00 
PU5-1.8 � ^ ^ ^ 
P388 D1 27 i00 fs ^ 
L929 40 loO 0 ^ 
~ ~ N m 3 T 3 45 i[^ n ^ 
EAT 55 l00 l5 S 
YAC-1 ^ ^ 1^  ^ 
MBL-2 40 ] ^ l0 > I ^ 
tIC5o value is the concentration of flavonoid, which can cause 50% inhibition of 
^H-TdR incorporation. 
JOptimal concentration is the concentration of flavonoid in which the inhibition 
reaches a plateau. 
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3.2.5 Effects of Flavone and Flavonol on the Cell Cycle Kinetics of JCS 
Cells 
The cell cycle kinetics of flavone- and flavonol-treated JCS cells were 
analyzed by flow cytometry (Figure 3.12 and 3.13). The results in Table 3.6 
show that there was a marked decrease in the percentage of cells in the S 
phase, with a proportional increase in the percentage of JCS cells in the Go/Gi 
phase, when JCS cells were incubated with flavone (0-50 p,M) or flavonol (0-
25 \xM) for 72 hours. 
Table 3.4: Effect of flavone and 3-hydroxyflavone on cell cycle distribution of 
JCS ceUs. 
~~Conc. ofFlavone or~~ %ofCells 
3-OH Flavone Go/Gi phase S phase G � + M phase 
(\xM) 
~~Control 4Z8 5 U ^ 
Flavone 25 ^ ^ 4.5 
^ 77^ r ^ T3 
~"3-OH n ^ 5 ^ ^ 11.2 
Flavone 25 ^ f ^ « 
JCS cells (lxlO^ cells/ml) were incubated with different concentrations of flavone (0-
50 ^M) and 3-hydroxyflavone (0-25 ^M) at 37^ C for 72 hours. The DNA was 
stained with propidium iodide and the fluorescence intensity was analyzed with a 
flow cytometer. The percentage of cell at different phases of the cell cycle was 
calculated by the CELLFIT program, using the rectangle fit (RPIT) analysis model. 
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Figure 3.12: Effect offlavone on ceU cycle profile of JCS ceUs. JCS cells (lxlO^ 
cells / ml) were incubated with different concentrations offlavone (0-50 ^iM) at 37^C 
for 72 hours. Flavone-treated JCS cells (lxlO^) were fixed with ethanol and stained 
with propidium iodide under hypotonic conditions. Propidium iodide-stained cells 
were analyzed for fluorescence intensity using FACSort flow cytometer. Cell cycle 
distribution was calculated by the CELLFIT program using the rectangle fit (RFIT) 
analysis model. JCS cells were cultured in [A] culture medium; [B] flavone 
(25 |iM); [C] flavone (50 ^M). Cells in S phase were represented by the red rectangle. 
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Figure 3.13: Effect of 3-hydroxyflavone on cell cycle profile of JCS cells. JCS cells 
(lxlO^ cells / ml) were incubated with different concentrations of 3_OH flavone 
(0-25 i^M) at 3TC for 72 hours. 3-OH flavone-treated JCS cells (lxlO^) were fixed 
with ethanol and stained with propidium iodide under hypotonic conditions. Propidium 
iodide-stained cells were analyzed for fluorescence intensity using FACSort flow 
cytometer. Cell cycle distribution was calculated by the CELLFIT program using the 
rectangle fit (RFIT) analysis model. JCS cells were cultured in [A] culture medium; 
[B] 3-OH flavone (12.5 ^M); [C] 3-OH flavone (25 i^M). Cells in S phase were 
represented by the red rectangle. 
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3.2.6 Induction ofDNA Fragmentation ofJCS cells by Flavone 
There was evidence that flavonoids could induce apoptosis in a variety 
of cell types, and the death associated with terminally differentiated cells was 
known as apoptosis (Constaninou et al.’ 1990; Cotter et aL, 1990; Hirano et 
al., 1995). In the present study, the ability of flavone to induce apoptosis in 
JCS cells was examined. As shown in Figure 3.12, the induction of apoptosis 
was indicated by the hypodiploid peak and a decrease in cells in S phase. 
The qualitative analysis of DNA fragmentation, which is a 
characteristic of apoptosis, was performed by the agarose gel electrophoresis. 
The presence ofoligonucleosomal (180-200 bp) DNA fragments was regarded 
as an indicator ofapoptosis. As shown in Figure 3.14，no DNA fragmentation 
was found in untreated JCS cells or in JCS cells treated with flavone (50 pM) 
for 2 hours. However, there was an increase in DNA fragmentation as the 
incubation time increased from 8 hours to 24 hours. 
The appearance of morphological features of apoptotic cell death was 
also monitored on cytocentrifuge preparations. The results revealed that 
apoptotic morphology in JCS cells was elicited by flavone at a concentration 
of 50 i^M (Figure 3.15). The apoptotic morphology was observed along with 
the monocytic differentiation of the JCS cells. 
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Figure 3.14: Induction ofDNA fragmentation in flavone-treated JCS ceUs. JCS 
cells (1x10) were incubated with flavone (50 ^M) at 37�C for different periods of 
time (from 2 to 24 hours). Apoptotic DNA fragments were isolated by the mild 
detergent NP-40 (3%) lysis buffer, and were then analyzed by electrophoresis on 2% 
agarose gel stained with ethidium-bromide. 
Lane 1: 100 bp DNA ladder Lane 4: Flavone-treated JCS cells 
Lane 2: Flavone-treated JCS cells (12 hours) 
(2 hours) Lane 5: Flavone-treated JCS cells 
Lane 3: Flavone-treated JCS cells (24 hours) 
(8 hours) Lane 6: Untreated JCS cells 
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Figure 3.15: Expression of apoptotic morphology in flavone-treated JCS ceUs. 
JCS cells (lxlO^ cells / ml) were incubated with different concentrations (0-50 i^M) of 
flavone at 3 7 � � f o r 72 hours. The cells were cytocentrifuged onto the microscopic 
slide, and were stained with modified Wright-Giemsa stain. Theapoptotic cells were 
indicated by the arrow. JCS cells were cultured in [A] culture medium; [B]flavone 
(25 ^M) and [C] flavone (50 ^M). (Magnification x400) 
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3.2.7 Effect of Flavone on the Clonogenicity of JCS Cells In Vitro and 
Tumorigenicity In Vivo 
Apart from exerting anti-proliferative activity on JCS in vitro, the 
influence of flavone on the clonogenicity of JCS cells in vitro and the 
tumorigenicity of JCS cells in vivo were also investigated. When the effect of 
flavone on the colony-forming ability of JCS cells in soft agar was studied, it 
was found that the capacity of flavone-treated JCS to form colonies in vitro 
was reduced in a dose-dependent manner, with the cloning efficiency reduced 
from 38.5% in untreated cells to 2.3 % in 50 ^M flavone-treated JCS cells 
(Table 3.5). 
Table 3.5: Effect of flavone on colony-forming ability ofJCS cells in soft agar. 
Conc. of flavone Number of colonies in % cloning efficiency in soft 
(^M) soft agar agar 
0 77.0土 2.81 38.5± 1.40 
n ^ 46.7 土 0.72 23.3 士 0.36* 
25 44.0土 1.67 22.0 ± 0.84** 
50 4.5±0.50 2.3 ± 0.25** 
JCS cells (200 cells in each well of soft agar) were incubated with different 
concentrations of flavone (0-50 i^M) at 37°C for 7 days. After hemoxylin staining, 
the number of colonies containing more than 50 cells was counted. Results from 
triplicate experiments were expressed as % cloning efficiency in soft agar, which 
represents the number of colonies/100 cells initially plated in soft agar plate. 
Significantly different from untreated cells: * p<0.05; ** p<0.001. 
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Moreover, the ability of flavone-treated JCS cells to induce tumor 
growth in syngeneic BALB/c mice was also studied. The results in Table 3.6 
show that flavone treatment of JCS cells in vitro significantly decreased .the 
leukemia cell growth in vivo. 
Table 3.6: Effect of flavone treatment on tumorigenicity of the JCS ceUs in 
BALB/c mice. 
Conc. of flavone Tumor ceU no. in peritoneal cavity 
( _ (X 106) 
0 881 土 22.3 
25 421 ± 17.2 
‘ ^ 214土 9.8* 
JCS ceUs (104 cells/ml) were incubated with different concentrations of flavone (0-50 
i^M) for 3 days at 37°C. The cells were washed three times with RPMI medium and 
lxlO^ viable cells were injected intraperitoneally into BALB/c mice in groups of five. 
Tumor cells recoverable from the peritoneal cavity of mice were counted at day 14 
post-tumor inoculation. 
Significantly different from untreated cells: * p<0.05. 
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3.3 DISCUSSION 
Ln the present study, the effects of flavone and flavonol derivatives on 
the proliferation and apoptosis of murine myeloid leukemia JCS were 
investigated. Using the thymidine incorporation assay, it was shown that 
flavone inhibited the proliferation of JCS cells in a dose-dependent manner. 
Similar results were also obtained using other parameters for measuring the 
anti-proliferative activity of flavone, such as counting the number of viable 
cells by the trypan blue exclusion assay and measuring the mitochondrial 
dehydrogenase activity of viable cells detected by the MTT assay. The 
present results also show that the anti-proliferative activity of flavone on the 
JCS cells could not be attributed to the direct cytotoxicity of flavone on the 
leukemia cells, since flavone at a concentration of 50 ^M or less did not 
exhibit significant cytotoxic activity to JCS cells and normal murine 
lymphocytes, as determined by the trypan blue exclusion assay. Our results 
are similar to that of Hirano et al. (1994)，who showed that flavonoids 
inhibited the cell growth ofthe human leukemic HL-60 and MOLT-4 cells by 
a non-toxic mechanism, possibly via the inhibition ofthe DNA, RNA andA)r 
protein synthesis of the leukemia cells (Hirano et aL, 1994). 
The differential growth-inhibitory effect of different flavone and 
flavonol derivatives on JCS cells was also investigated by the thymidine 
incorporation assay. It was found that JCS cells exhibited differential 
sensitivities to different flavone and flavonol derivatives, with IC50 values 
ranged from 10 to 200 ^M for JCS cells (Table 3.2). It can be seen that 3-
hydroxyflavone displayed the most potent cytostatic effect on JCS cells, 
followed by myricetin, flavone and 6-hydroxyflavone. Li contrast, morin 
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hydrate (2‘,3,4',5,7-pentahydroxyflavone) was found to be the much less 
effective in inhibiting the growth of JCS cells with IC50 value greater than 200 
i^M. Our results, though preliminary, indicate that there is no direct structure-
activity correlation of flavone and flavonol derivatives for their anti-
proliferative activity on the leukemia JCS cells. Similarly, others have 
reported that there is no apparent structure-activity relationships for the 
cytostatic and cytotoxic activities of flavonoid derivatives on various animal 




Among the different tumor cell lines tested for their sensitivities to the 
growth-inhibitory effect of flavone and flavonol, the murine myeloid leukemic 
JCS and Ml cell lines were found to be the most sensitive to the anti-
proliferative activity of flavone and flavonol. Since the murine 
myelomonocytic leukemia cell line WEHI-3B JCS was subcloned and well-
characterized (Mak et aL, 1993)，it was chosen as the cell model for further 
studies on effects of flavonoids on modulating the proliferation, differentiation 
and survival ofmyeloid leukemia cells. 
Results in this study also show that the colony-forming ability of JCS 
cells in vitro and their tumorigenicity in vivo was inhibited by flavone 
treatment. The cloning efficiency of flavone-treated JCS was decreased in a 
dose-dependent manner and the appearance of colony also changed from 
compact cells to the colonies of dispersed cells with a corona of differentiating 
cells around a tight central region after flavone treatment (Metcalf and Nicola, 
1982). On the other hand, the JCS cells recoverable from the peritoneal cavity 
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were also significantly reduced if the cells were pre-treated with flavone for 72 
hours. Collectively, these results indicate that flavone not only can markedly 
inhibit the proliferation ofleukemia JCS cells in vitro, but also can reduce the 
leukemic cell growth in vivo. 
From the result of the cell cycle analysis by flow cytometry, upon 
treatment of the JCS cells with flavone and flavonol, there was a marked 
decrease in cells cycling at S phase which was accompanied by growth arrest 
in the Go/Gi phase. Our results are consistent with that of Yoshida and co-
workers (1992), who showed that quercetin (3,3 ‘,4‘,5,7-pentahydroxyflavone) 丨 
. i 
inhibited the growth of malignant cells and arresting them in the late Gi phase 丨 
of the cell cycle. Jn contrast, using a human breast cancer cell line MDA- ！ 
I 
MB468, Avila and co-workers (1994) demonstrated that quercetin inhibited 丨 
I 
I 
the cell growth and cell cycle progression of the tumor cells, arresting them at 
the G2-M phase. The discrepancy in these findings remains unclear, but it 
could be due to the different tumor eell system being studied (Avila et al., 
1994). 
In the present study, flavone at a concentration of 50 ^M was found to 
induce significant DNA fragmentation in JCS cells 8-24 hours after in vitro 
incubation. On the other hand, Csokay and co-workers (1997) showed that 
DNA fragmentation in the human leukemia K562 cells appeared shortly (1 
hour) after quercetin exposure at a concentration of 55 |iM or above. The 
molecular mechanisms by which flavonoids can induce apoptosis in leukemia 
cells are as yet unclear, but a close relationship between the cell cycle arrest, 
apoptosis and monocytic differentiation of the myeloid leukemia cells has 
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been suggested (Constaninou et al, 1990; Cotter et al., 1990; Elias and Berry, 
1991; Csokay et al, 1997). Further studies on the differentiation-inducing 
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Ch. 4 Induction ofMonocvtic Cell Differentiation 
4.1 INTRODUCTION 
Lti general, the process of the induced differentiation is characterized 
by the cessation of proliferation and expression of surface markers typical for 
myeloid cells, including the Fc receptor and the I region-associated (Ia) 
antigen (Fibach et al., 1973; Guyre et al., 1983). Furthermore, the 
heterogeneity in functions, morphology and phenotypic markers were also 
identified as markers of cell differentiation (Larson and Springer, 1990; 
Ricciardi-Castagonli and Paglia, 1992; Leenen et al., 1994). Along the 
differentiation pathway of mature monocytes, the induction of several . 
j 
monocyte-specific enzymes such as the lysozyme, esterase and type IV 
• ' i 
• 'ii 
1； 
collagenase followed the phenotypic markers expression. Subsequently, the 
increases in fbactional characteristics such as the nitric oxide and superoxide ( 
I I j ] 
anion generation, endocytic and phagocytic activities are also observed 
i 
(Sachs, 1978; Leung et aL, 1994). :丨 
II 
It has been reported that certain flavonoids have the capacity to induce 
the differentiation of malignant cells to a mature phenotype. For example, | 
I 
genistein, an isoflavone, had been shown to induce the differentiation and 
acquisition of maturation markers in the human promyelocytic leukemia 
HL-60 cells and erythroleukemia K-562 cells (Wantanabe et aL, 1989; 
Constaninou et aL, 1990). On the other hand, a number of highly 
methoxylated flavones isolated from Citrus species were found to have 
differentiation-inducing activity towards the mouse myeloid leukemia Ml 
cells and the human leukemia HL-60 cells (Sugiyama et aL, 1993). Despite 
these fmdings, the mechanisms by which flavonoids can modulate the 
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differentiation of myeloid leukemia cells and the factors that might lead to 
lineage-restricted leukemic cell differentiation remain poorly understood. 
The mouse myeloid leukemia JCS cells are known to be induced to 
differentiate into macrophage-like cells by various inducers, such as phorbol 
12-myristate 13-acetate (PMA) (Mak et al, 1993), lipopolysaccharide (LPS) 
(Chan et al, 1995), B^-la and E^-lp (Chan et al., 1997)，TNP-a and EFN-y 
(Mak et al., 1993; Suh et al., 1995). Nevertheless, whether JCS cells can be 
induced to differentiate by flavonoids has not yet been elucidated. Li view of 
I 
the potent anti-proliferative activity of flavonoids on JCS cells (Chapter 3), 
therefore, in this chapter, the differentiation-inducing activity of flavone and 
flavonol (3-hydroxyflavone) on JCS cells was assessed using a number of l 
I 
phenotypic and functional criteria. The morphological changes, surface 
antigen immunophenotyping and acquisition of phagocytic, endocytic and 
non-specific esterase activities were investigated. 
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4.2 RESULTS 
4.2.1 Morphological Changes in Flavonoid-Treated JCS Cells 
Apart from exhibiting potent anti-proliferative effect on the murine 
myeloid leukemia JCS cells, flavone and flavonol (3-hydroxyflavone) also 
induced the monocytic differentiation of the cells in a dose-dependent manner. 
This was confirmed by examination of cytocentrifiige preparations. Cell 
morphology was analyzed on the modified Wright-Giemsa stained cell smears 
and differential cell counts were performed. The JCS cells were scored as 
blast cells (myeloblasts and promyelocytes), intermediate stage cells “ 
. ！ 
(myelocytes and promonocytes) and mature cells (macrophage-like cells) , 
‘ I 




Figure 4.1 and Figure 4.2 show that most of the untreated JCS cells j' 
i 
(�93%) remained at the blast stage. When JCS cells were treated with a sub- ：, 
optimal dose of flavone (25 ^M), they proceeded along the differentiation ‘ 
, I 
pathway with a marked increase in the proportion of cells in the intermediate I 
I ] 
stage. JCS cells that were exposed to an optimal dose of flavone (50 pM) 
obviously underwent monocytic differentiation, with �47o/o of the cells 
reached the mature stage. Similar results were obtained with the 3-
hydroxyflavone-treated JCS cells, the proportion of cells reaching terminally 
differentiated stage were found to be � 3 4 % , when JCS cells were exposed to 
an optimal dose of 3-hydroxyflavone (25 pM). 
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Table 4.1: Morphological differentiation of flavone- and 3-hydroxyflavone-
treated JCS cells. 
% of cells (mean 土 standard error) 
Concentration of flavonoids Blast cells Intermediate Mature 
(jjM) stage cells macrophages-
like cells 
Control 93.2t2.48 6.8 土 2.48 0 
Flavone 25 19.75± 1.79 76.65±2.17 3.5±0.5 
> ^ ^ ^ _ ^ ^ _ _ _ ^ ^ _ _ ^ _ _ ^ _ ^ _ ^ _ _ _ _ _ _ ^ _ ^ ^ ^ _ ^ _ _ _ _ _ _ _ ^ ^ _ ^ _ _ ^ _ _ _ _ _ _ _ _ ^ _ ^ ^ ^ _ _ _ ^ ^ _ _ _ _ ^ ^ ^ ^ ^ _ _ _ ^ ^ _ _ ^ _ _ ^ _ _ _ _ ^ ^ ^ _ ^ _ 
50 5 土 2.45 48.28土2.86 46.75±3.34 
3-OH i ^ 36 土 2.74 61.25±4.02 2.75±1.48"““ 
flavone ^ 14.67 士 4.5 61.67±4.99 33.67±2.05 
i t ( 
fl 
JCS cells (lxlO^ cells / ml) were incubated with different concentrations of flavone ‘ 
i 
(0-50 i^M) and 3-hydroxyflavone (0-25 i^M) at 37°C for 72 hours. The cells were fi 
'3 
cytocentrifuged onto the microscopic slide and stained with Wright-Giemsa stain for ！ 
i » i 
morphological identification of the cells. Differential counts were performed by ;) 
counting at least 300 cells, and the cells were scored as blast cells (myeloblasts and l| 
promyelocytes), intermediate stage cells (myelocytes and promonocytes) and mature | 
cells (macrophage-like cells). The resuks were expressed as mean 土 standard error. i; 
丨  
I ' 
Apart from morphological examination of the cytocentrifuge | 
i 
preparations, FACS analysis on forward scatter versus 90° scatter was also 丨 
performed to give a relative measure of cell size and cell granularity. The 
results obtained also agreed with the morphological observation, reflecting the 
marked increase in both the cell size and cell granularity (Figure 4.3 and 
Figure 4.4) in the differentiating JCS cells induced by flavone and 
3-hydroxyflavone. 
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Figure 4.1: Morphological changes offlavone-treated JCS ceUs. JCS cells (1x10 
cells / ml) were incubated with different concentrations (0-50|iM) of flavone at 37<>C 
for 72 hours. The cells were cytocentrifuged onto the microscopic slide, and were 
stained with modified Wright-Giemsa stain. JCS cells were cultured in [A] culture 
medium; [B] flavone (25 i^M) and [C] flavone (50 i^M). (Magnification x400) 
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Figure 4.2: Morphological changes of 3-hydroxyflavone-treated JCS ceUs. JCS 
cells (lxlO^ cells / ml) were incubated with different concentrations (0-25 \xM) of 
3-OH flavone at 3 7 � � f o r 72 hours. The cells were cytocentrifuged onto the 
microscopic slide, and were then stained with modified Wright-Giemsa stain. JCS 
cells were cultured in [A] culture medium; [B] 3-OH flavone (12.5 i^M) and [C] 3-OH 
\ 
flavone (25 i^M). (Magnification x400) 
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Figure 4.3: FACS analysis of light scattering properties of flavone-treated JCS 
cells. JCS cells (1 x 10^  cells / ml) were incubated with different concentrations of 
flavone (0-50 ^M) at 37°C for 72 hours. Cells were then fixed with 
paraformaldehyde and (1 x 10^  cells) were analyzed for light scattering properties 
using the FACSort flow cytometer. JCS cells were cultured in [A] culture medium; 
[B] flavone (25 i^M) and [C] flavone (50 ^ M). 
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Figure 4.4: FACS analysis of light scattering properties of 3-hydroxyflavone-
treated JCS ceUs. JCS cells (1 x 10^  ceUs / ml) were incubated with different 
concentrations of 3-OH flavone (0-25 _ at 37�C for 72 hours. Cells were then 
fixed with paraformaldehyde and (1 x 10^  cells) were analyzed for light scattering 
properties using the FACSort flow cytometer. JCS cells were cultured in [A] culture 
medium; [B] 3-OH flavone (12.5 i^M) and [C] 3-OH flavone (25 ^ iM). 
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4.2.2 Induction ofPlastic Adherence in Flavonoid-Treated JCS Cells 
The monocytic differentiation of myeloid leukemia cells is usually 
accompanied by a number of morphological changes. Apart from the 
morphological changes as mentioned above, the increase in adherence to 
plastic surface was also observed (Mak et al.’ 1993). It was found that the 
percentage of JCS cells that adhered to plastic surface was increased from 
2 土 0.23o/o of the untreated cells to 27.2 土 2.1% and 25.3 土 1.2o/o after 
treatment with flavone (50 |iM) and 3-hydroxyflavone (25 ^M) respectively 







4.2.3 Surface Antigen Immunophenotyping of Differentiating JCS Cells ！ 
_ ； 
It has been reported that a number of lineage-specific and lineage-non- , 
specific differentiation antigens may be expressed on the surface of myeloid , 
cells during cell differentiation and development (Ralph et al” 1983; ； 
i \ 
Ricciardi-Castagonli and Paglia, 1992; Leenen et al., 1994). These surface 
• 
antigens can be identified by flow cytometry using monoclonal antibodies. i 
I 
( 
From FACS analysis, it can be seen that flavone and 3-hydroxyflavone 
treatment induced phenotypic changes in the JCS cells. The change was 
associated with the acquisition of mature macrophage/monocyte 
characteristics. The expression of the macrophage differentiation antigens 
(Mac-1 and F4/80) on the surface of JCS cells was also increased (Figure 4.5 -
4.8). Moreover, the flavone-treated JCS cells were also induced to express 
certain adhesion molecules, such as intercellular adhesion moelcule-1 (ICAM-
1) (Figure 4.9)，vascular cell adhesion molecule-1 (VCAM-1) (Figure 4.10) 
and lymphocyte function-associated antigen-1 (LFA-1) (Figure 4.11). 
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Figure 4.5: FACS analysis of Mac-1 antigen expression onflavone-treated JCS 
ceUs. JCS cells (1 x 10^  cells / ml) were incubated with different concentrations of 
flavone (0-50 |iM) at 370C for 72 hours. Cells were then stained with monoclonal 
antibody to Mac-1 antigen. The paraformaldehyde-fixed cells (1 x 10^  cells) were 
analyzed for fluorescence intensity using the FACSort flow cytometer. JCS cells were 
cultured in [A] culture medium; [B] flavone (25 i^M) and [C] flavone (50 juM). The 
x-axis was plotted in logarithmic scale. 
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Figure 4.6: FACS analysis of F4/80 antigen expression onflavone-treated JCS 
ceUs. JCS cells (1 x 10^  cells / ml) were incubated with different concentrations of 
flavone (0-50 |iM) at 3>l^ C for 72 hours. Cells were then stained with monoclonal 
antibody to F4/80 antigen. The paraformaldehyde-fixed cells (1 x 10^  cells) were 
analyzed for fluorescence intensity using the FACSort flow cytometer. JCS cells were 
cultured in [A] culture medium; [B] flavone (25 ^M) and [C] flavone (50 i^M). The 
x-axis was plotted in logarithmic scale. 
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Figure 4.7: FACS analysis of Mac-1 antigen expression on 3-hydroxyflavone-
treated JCS cells. JCS cells (1 x 10^  cells / ml) were incubated with different 
concentrations of 3-OH flavone (0-25 fiM) at 37�C for 72 hours. Cells were then 
stained with monoclonal antibody to Mac-1 antigen. The paraformaldehyde-fixed cells 
(1 X 10^  cells) were analyzed for fluorescence intensity using the FACSort flow 
cytometer. JCS cells were cultured in [A] culture medium; [B] 3-OH flavone (12.5 
p,M) and [C] 3-OH flavone (25 ^M). The x-axis was plotted in logarithmic scale. 
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Figure 4.8: FACS analysis of F4/80 antigen expression on 3-hydroxyflavone-
treated JCS ceUs. JCS cells (1 x 10^  cells / ml) were incubated with different 
concentrations of 3-OH flavone (0-25 |xM) at 370C for 72 hours. Cells were then 
stained with monoclonal antibody to F4/80 antigen. The paraformaldehyde-fixed 
cells (1 X 10^  cells) were analyzed for fluorescence intensity using theFACSort flow 
cytometer. JCS cells were cultured in [A] culture medium; [B] 3-OHflavone (12.5 
^M) and [C] 3-OH flavone (25 ^M). The x-axis was plotted in logarithmic scale. 
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Figure 4.9: FACS analysis of ICAM-1 antigen expression onflavone-treated JCS 
ceUs. JCS cells (1 x 10^  cells / ml) were incubated with different concentrations of 
flavone (0-50 ^M) at 370C for 72 hours. Cells were then stained with monoclonal 
antibody to ICAM-1 antigen. The paraformaldehyde-fixed cells (1 x 10^  cells) were 
analyzed for fluorescence intensity using the FACSort flow cytometer. JCS cells were 
cultured in [A] culture medium; [B] flavone (25 |iM) and [C] flavone (50 i^M). The 
x-axis was plotted in logarithmic scale. 
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Figure 4.10: FACS analysis of VCAM-1 antigen expression onflavone-treated 
JCS ceUs. JCS cells (1 x 10^  cells / ml) were incubated with different concentrations 
offlavone (0-50 ^M) at 3 7 � � f o r 72 hours. Cells were then stained with monoclonal 
antibody to VCAM-1 antigen. The paraformaldehyde-fixed cells (1 x 10^  cells) were 
analyzed for fluorescence intensity using the FACSort flow cytometer. JCS cells were 
cultured in [A] culture medium; [B] flavone (25 i^M) and [C] flavone (50 i^M). The 
x-axis was plotted in logarithmic scale. 
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Figure 4.11: FACS analysis of LFA-1 antigen expression onflavone-treated JCS 
ceUs. JCS cells (1 x 10^  cells / ml) were incubated with different concentrations of 
flavone (0-50 ^M) at 37^ C for 72 hours. Cells were then stained with monoclonal 
4 
antibody to LFA-lantigen. The paraformaldehyde-fixed cells (1 x 10 cells) were 
analyzed for fluorescence intensity using the FACSort flow cytometer. JCS cells were 
cultured in [A] culture medium; [B] flavone (25 ^M) and [C] flavone (50 |nM). The 
x-axis was plotted in logarithmic scale. 
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4.2.4 NBT-Reducing Activity ofFlavonoid-Treated JCS Cells 
It was found that normal mature macrophages and granulocytes could 
produce superoxide anions when stimulated with DMSO and actinomycin 
(Koeffler et al., 1985). Superoxide anions can reduce the water-soluble NBT 
to produce blue-black nitroblue diformazan QSHBD) deposits. Morphological 
assessment of Wright-Giemsa-stained cytospin slides shows good correlation 
between NBT reduction and the number of cells that are 
monocytes/macrophages (Breitman, 1990). In the present study, the untreated 
JCS cells exhibited little or no NBT-reducing activity, but treatment with „ 
flavone (25-50 i^M) and 3-hydroxyflavone (12.5-25 |iM) significantly | 
I 
i 




Table 4.2: Stimulatory effect of flavone and 3-hydroxyflavone on the NBT- 丨 
reducing activity of JCS cells. < 
Concentration offIavonoids (^iM) % NBT+ cells I 
Control 6.11土0.87 , 
Flavone 25 3 2 士 1 * 
5 0 — 5 5 . 6 7 ± 1 . 0 3 * ！ 
3 - O H 1 2 . 5 — 3 2 . 3 3 士 4 . 5 * 
flavone 25 5 9 土 1 . 2 * * ‘ 
JCS cells (lxlO^ cells / 200 i^l) were incubated with different concentrations of 
flavone (0-50 i^M) and 3-hydroxyflavone (0-25 jiM) at 37�C for 72 hours. The 
superoxide anion production can be measured by the reduction of nitroblue 
tetrazolium dye to water insoluble intracellular blue-black formazan. The percentage 
of NBT-positive 0STBT+) cells was determined by counting at least 300 cells under 
light microscopy, and the results were expressed as mean 土 standard error. 
Significantly different from untreated cells * p<0.05; ** p<0.001. 
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4.2.5 Non-specific Esterase Activity ofFlavonoid-treated JCS Cells 
Apart from expressing the surface markers for differentiated myeloid 
cells, monocytic differentiation is also evidenced by the induction of 
monocyte-specific enzyme, such as the non-specific esterase and the amount 
ofenzyme is directly proportional to the maturation stage along the monocytic 
pathway (Robinson et aL, 1994). The non-specific esterase activity can be 
assessed by fluorescein diacetate staining, followed by the analysis of 
fluorescent intensity by flow cytometry. The results in Figure 4.12 show that 
the fluorescent intensity increased after treatment with flavone (25-50 |iM) 
H I 




esterase activity in differentiating JCS cells. | 
I 
— o. ！ 
^ 1 1 Untreated JCS cells ^H 丁，‘ ‘ ^ 了广。„ gN Untreated JCS cells 
5 1 Flavone-treatedJCS 3-OHFlavone-treated ‘ 
^ I . ceUs (25 nM) . JCS cells (12.5 i^M) J 
U M A F h m m e - t r e a t e d J C S A | 3-OHFIavone-treated ‘ 
^ 1 cells(5G^iM) / 1 ¾ JCScells(25^M) ' I 11 w . ； 
U 。 \ A > \ 乂”. O.V…… , ,W..^ .,、…….7. I 
10« 10i 10' 10' io4 10^  10^  10" 10^  10^ 
Fluorescence Intensity 
Figure 4.12: Induction of non-specific esterase activity in flavone and 3-
hydroxyflavone-treated JCS cells. JCS cells (1 x 10^  cells / ml) were incubated 
with different concentrations of flavone (0-50 ^M) and 3-OH flavone (0-25 |aM) at 
37°C for 72 hours. Non-specific esterase activity was determined by fluorescein 
diacetate staining, using untreated JCS cells as control. The paraformaldehyde-fixed 
cells (1 X 10^  cells) were analyzed for fluorescence intensity using the FACSort flow 
cytometer. The x-axis was plotted in logarithmic scale. 
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4.2.6 Endocytic Activity of Flavononoid-Treated JCS Cells 
Endocytic activity of the differentiating JCS cells was determined by 
the uptake ofthe FITC-conjugated bovine serum albumin (FITC-BSA), and it 
was analyzed by flow cytometry. The results show that a significant 
enhancement of endocytic activity was observed, after JCS cells were 
incubated with flavone (25-50 i^M) and 3-hydroxyflavone (12.5-25 i^M) for 72 
hoursat37^C(Figure4.13). 
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Figure 4.13: Induction of endocytic activity in flavone- and 3-hydroxyflavone-
treated JCS cells. JCS cells (lxlO^ cells / ml) were incubated with different 
concentrations of flavone (0-50 |xM) and 3-OH flavone (0-25 i^M) at 37°C for 72 
hours. Endocytic activity was determined by the uptake of FITC-BSA using 
untreated JCS cells as control. The paraformaldehyde-fixed cells (lxlO^ cells) were 
analyzed for fluorescence intensity using the FACSort flow cytometer. The x-axis 
was plotted in a logarithmic scale. 
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4.2.7 Phagocytic Activity ofFlavonoid -Treated JCS Cells 
The phagocytic activity of the macrophages and neutrophils, in which 
the large particles (latex in this case) can be internalized, was measured by the 
ingestion of FITC-conjugated latex (FITC-latex), and the fluorescent intensity 
was analyzed by flow cytometry. The results in Figure 4.14 show that the 
phagocytic activity was enhanced after the treatment of JCS cells with flavone 
(25-50 i^M) and 3-hydroxyflavone (12.5-25 i^M) for 72 hours at 37°C. 
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Figure 4.14: Induction of phagocvtic activity in flavone- and 3-hydroxyflavone-
treated JCS cells. JCS cells (lxlO^ cells / ml) were incubated with different 
concentrations offlavone (0-50 i^M) and 3-hydroxyflavone (0-25 i^M) at 37�C for 72 
hours. Phagocytic activity was determined by the uptake of FITC-latex using 
untreated JCS cells as control. The paraformaldehyde-fixed cells (lxlO^ cells) were 
analyzed for fluorescence intensity using the FACSort flow cytometer. The x-axis 
was plotted in a logarithmic scale. 
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4.3 DISCUSSION 
Certain flavonoids have been reported to have anti-proliferative and 
differentiation-inducing activity on different tumor cell lines, including the 
leukemia cell lines (HL-60 and K562) (Wantanabe et al., 1989; Constaninou 
et al., 1990). The isoflavone, genistein, induced the differentiation of human 
myeloid HL-205 and erythroid K-562-J leukemia cells. The acquisition of the 
phenotypic and functional characteristics of mature cells was observed. For 
instance, the induced cells expressed the mature phenotype, the appearance of 
mature monocytic or granulocytic markers, the acquisition of staining for 丨  
» 
nonspecific esterase and NBT reducing ability (Constaninou et al., 1990; , 
Middleton and Kandaswami, 1993; Middleton, 1996). More recently, Csokay 
et al. (1997) showed that quercetin (3，3，，4’，5，7-pentahydroxyflavone) ( 
inhibited the growth and induced apoptosis and erythroid differentiation in 
，丨 
human leukemia K562 cells, and these processes were associated with the ‘ 
I 
transient down-regulation of c-myc and Ki-ras oncogene expression (Csokay 
•< 
etal, 1 9 9 7 ) . 、丨 
I 
In the present study, flavone and 3-hydroxyflavone were shown to 
have the capacity of inducing the monocytic differentiation of the myeloid 
leukemia WEffl-3B JCS cells in a dose-dependent manner (Section 4.2.1). 
Furthermore, the results show that JCS cells induced by flavone and 3-
hydroxyflavone had acquired the flmctional characteristics of mature 
macrophages, such as increased spreading and adherence to plastic surface 
(Section 4.2.2), induction of NBT reducing (Section 4.2.4) and non-specific 
esterase (Section 4.2.5) activities, as well as stimulation of endocytic (Section 
4.2.6) and phagocytic activities (Section 4.2.7). These findings suggest that 
U8 
Ch. 4 hidttCtion ofMonocytic CeM Differentiation 
the JCS cells were induced to differentiate into morphologically and 
phenotypically macrophage-like cells, which have the normal fmictional 
properties of mature macrophage, such as phagocytic and endocytic activities. 
Li addition, the surface expression of the macrophage differentiation 
antigens (Mac-1 and F4/80) on JCS cells was induced by flavone and 
V 
3-hydroxyflavone treatment (Section 4.2.3). The Mac-1 antigen is a 
differentiation antigen which is present in a variety of cell types, such as 
polymorphs, macrophages and natural killer cells (Springer et aL, 1979). The „ 
» 
enhanced Mac-1 expression in differentiating JCS cells was in agreement with , 
reports showing that Mac-1 antigen in JCS cells could be up-regulated by a 
variety of differentiation agents, including TNF-a, TNF-a plus JL-4, PMA or ！ 
IL-1 (Mak et aL, 1993; Leung et al., 1994; Chan et al., 1997). Similarly, the 
1丨 
expression of the macrophage-specific differentiation antigen F4/80 was also i 
found to be increased significantly in flavonoid-treated JCS cells. This � 
antigen was also expressed in the normal and mature macrophages (Starkey et 
\ 
al., 1987). , 
On the other hand, the expression of certain adhesion molecules 
(ICAM-1, VCAM-1 and LFA-1) on JCS cells was found to be slightly up-
regulated by flavone treatment. The intercellular adhesion molecule-1 
(ICAM-1) is expressed on monocyte and endothelial cells, and its expression 
is induced in myeloid leukemia cell lines after treatment with cytokines such 
as IFN-y, TNF-a and IL-lp and LPS (Wawryk et al., 1989; Most et al., 1992). 
The vascular cell adhesion molecule-1 (VCAM-1) is constitutively expressed 
on bone marrow stromal cells as well as myeloid cells, and its expression on 
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endothelial cells is up-regulated by inflammatory cytokines (Kinashi and 
Springer, 1994). Likewise, the leukocyte function associated molecule-1 
(LFA-1) was found on the surface oflymphocytes, neutrophils, monocytes and 
macrophages, which has a role in mediating leukocyte adhesion to 
endothelium in inflammatory response (Amaout et al., 1988). The induction 
of LFA-1 expression in differentiating JCS cells was consistent with other 
studies showing that high level ofLFA-1 expression was found on the surface 
of PMA-induced HL-60 cells which differentiated along the 
monocyte/macrophage pathway (Wawryk et al., 1989; Back et al., 1992). It is ,„ 
» 
well known that the adhesion molecules play an important role in the adhesion , 
of peripheral blood leukocytes to activated endothelium and then followed by 
the phagocyte migration which is an important step in the inflammatory I 
response (Amaout et aL, 1988; Wawryk et al., 1989 and Larson; Springer, 
V 
1990). The present fmdings are in agreement with the notion that low levels i 
of expression of these molecules on resting undifferentiated myeloid leukemia 丨 
JCS cells can prevent the cell-cell interactions, but their up-regulation after 
I 
flavone-triggered cell differentiation may allow efficient interactions with , 
other cellular mediators of the inflammatory response. 
The underlying cellular and molecular mechanisms by which 
flavonoids can trigger monocytic differentiation of myeloid leukemia cells 
remain obscure. It has been reported that the isoflavone, genistein, induced 
the differentiation of erythroid K562 and myeloid HL-205 leukemia cells 
(Constaninou et aL, 1990; Yamashita et aL, 1990; Austin et aL, 1992). Since 
genistein is an inhibitor of topoisomerase II and tyrosine kinase, it has been 
suggested that induction of differentiation by genistein was associated with its 
U0 
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effect on the double-strand breakage in DNA, possibly mediated by 
topoisomerase 11. Literestingly, Csokay et al (1997) showed that quercetin, an 
inhibitor of various tyrosine protein kinases and serine/threonine protein 
kinases (Hagiwara et al., 1988; Ferriola et al., 1989)，induced both apoptosis 
and differentiation in the human leukemia K562 cells. Similarly, in Chapter 3, 
flavone and 3-hydroxyflavone were found to induce DNA fragmentation in 
JCS cells. The relationships between induction of apoptosis, inhibition of 
protein phosphorylation and induction of cell differentiation by flavonoids 
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5.1 INTRODUCTION 
Hematopoiesis is a complex process in which the proliferation, 
differentiation, survival and functions of hematopoietic cells are tightly 
regulated and coordinated by a group of hematopoietic cytokines (Chabannon 
and Mannoni, 1994). On the contrary, the impairment of the balance between 
cell viability，proliferation and differentiation resulted from genetic changes is 
observed in leukemia. The multiplication of the immature cells continued 
with the failure of terminal differentiation, and there is an accumulation of 
growing cells at certain stages during hematopoiesis (Hozumi, 1983; Miaizumi "' 
and Breitman，1987; Degos, 1994). The blockade in the differentiation has 
been proven to be bypassed by various physiological and non-physiological 
I 
inducers (Sachs, 1982; Hozumi, 1983; Zhang et al., 1992). The differentiation 
therapy of leukemia, using the differentiation-inducing compounds or 丨 
combinations of various inducers, has been shown to be a new approach in 
I ； 
i 
leukemia treatment (Sachs, 1982; Hozumi, 1983; Zhang et aL, 1992). 
,' 
I 
The regulatory hematopoietic cytokines, which can induce the 丨 
. ) i i i 
differentiation of myeloid leukemia cells into mature macrophages or 
granulocytes, have been identified and include TNF-a, EFN-y, G-CSF, GM-
CSF, UF, TGF-p, n^-l, EL-4 and IL-6, etc. (Hozumi, 1983; Lotem and Sachs, 
1990 Lotem et al., 1991; Mak et aL, 1993). These cytokines may act 
individually, synergistically and antagonistically in regulating myeloid 
leukemia cell growth and differentiation in vitro. For examples, synergistic 
interactions between IL-l，EFN-P and TNP-a in inducing the differentiation of 
myeloid leukemia Ml cells had been reported (Onozaki et al., 1988). 
1 2 2 
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Moreover, the combination ofIL-4 and TNF-a was found to act in synergy in 
inhibiting cell proliferation and in inducing monocytic differentiation of a 
murine myelomonocytic leukemia (WEHI-3B JCS) cells, and also 
significantly reduced the clonogenicity of the leukemia cells in vitro and their 
tumorigenicity in vivo (Leung et aL, 1994). 
> 
Meanwhile, extensive studies have shown that various leukemia cell 
lines such as HL-60, ML-1 and U937 were induced to differentiate by 
chemical agents, cytokines, vitamin analogs and anti-leukemia drugs. Some : 
of the inducers were found to act in synergy. For example, the anti-
proliferative and differentiative effects on human leukemia cell lines HL-60, 
U937 and ML1 induced by EL-6，EFN-y or TNF-a were enhanced when 
combining with 1,25-dihydroxyvitamin D3 (Wang et aL, 1991; Duits et aL, 
|丨 
1992 and Zhang et al., 1992). Recently, combinations of differentiation 
inducers (e.g. retinoic acid, Vit. D3, EFNs) and chemotherapeutic agents (e.g. 
cytosine arabinoside (ara-C) and VP16) in low doses have been used for 
leukemia therapy (Hellstrom et aL, 1989; Zhang et aL, 1992). Many studies !： 
.ii: 
have shown that 1,25-dihydroxyvitamin D3 and retinoic acid are potent 
inducers of leukemia differentiation (Brietman et aL, 1980; Abe et aL, 1981; 
Tanaka et al., 1982)，and they can inhibit the proliferation and induce the 
leukemia cells to differentiate along the monocytic pathway in vitro. In 
addition, interactions between retinoic acid and Vit. D3 analogs on inhibition 
of cell growth and DNA synthesis, the induction of differentiation and loss of 
clonogenicity were also observed (Dore et aL, 1993，1994; Defacque et aL, 
1994). 
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Ln Chapter 3 and 4，flavone was shown to inhibit cell proliferation, 
induced apoptosis and triggered monocytic differentiation of the murine 
myelomonocytic leukemia WEHI-3B JCS cells. Li order to explore the 
therapeutic potential of flavone in the differentiation therapy of leukemia, 
therefore, in this chapter, the effects of flavone in combinations with various 
hematopoietic cytokines (EFN-y, EL-la and EL-ip) and physiological inducers 
(1,25-dihydroxyvitamin D3 and all-trans retinoic acid (ATRA)) in regulating 
the proliferation and differentiation of JCS cells were examined. 
' I I 
In order to study the molecular mechanism by which flavone can exert 
its differentiative effect on JCS cells, the profile of cytokine gene expression 
in flavone-treated JCS cells was studied in this chapter. The Reverse 
Transcription-Polymerase Chain Reaction (RT-PCR) was employed to study 
the effect of flavone on the induction of cytokine gene expression during 
different time course of JCS differentiation. Semi-quantitative analysis was 
made by cycle titration followed by dot blot hybridization of the PCR products 
using the specific internal probes. 丨 
- i i . 
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5.2 RESULTS 
5.2.1 Combinations of Flavone with Physiological Differentiation 
Inducers on the Proliferation and Differentiation ofJCS Cells 
5.2.1.1 Modulatory Effects of Flavone and All-Trans Retinoic Acid 
(ATRA) on the Proliferation and Differentiation ofJCS Cells 
�JCS cells were incubated with different concentrations of flavone 
(0-25 \xM) and all-trans retinoic acid (ATRA) (0-5 ^M) for 48 hours, and the 
cell proliferation was determined by tritiated thymidine incorporation assay. 
i i i i 
As shown in Figure 5.1, ATRA alone exhibited a small inhibitory effect (~ 15-
20% inhibition) on the proliferation of JCS cells at concentrations of 1-5 jjM. 
However, ATRA significantly enhanced the inhibitory effect of flavone on 
JCS cell proliferation (Figure 5.1), and an additive effect was observed when 
I I 
the concentration of flavone was 25 ^M. 
The differentiation-inducing activity of ATRA on JCS cells was 
I 
studied by examining the morphological changes on the cytocentrifuge 
preparations, and a dose-dependent induction of monocytic differentiation of ""' 
JCS cells was observed (Figure 5.2). However, combination of flavone (12.5 
(jM) and ATRA (1 i^M) acted in synergy to induce monocytic differentiation 
of JCS cells (Figure 5.3). It can be seen that JCS cells treated with flavone 
(12.5 p,M) or ATRA (1 ^M) alone exhibited little or no morphological changes 
after incubation at 37�C for 72 hours (Figure 5.3B, 5.3C). ]b contrast, JCS 
treated with flavone and ATRA demonstrated significant morphological 
changes (Figure 5.3D), with increases in cell size, cytoplasm-nucleus ratio, 
l_25 
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vacuolation and apoptotic appearance when compared with untreated control 
cells (Figure 5.3A). 
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Figure 5.1: Effect of flavone and aU-trans retinoic acid (ATRA) on the inhibition 
of JCS cell proliferation. JCS cells (2xl0^ / 200 i^l) were incubated at 37�C with 
flavone (0-25 ^M) in the presence of ATRA (0-5 pM) for 48 hours. Cultures were 
then pulsed with 0.5 ^Ci of H^-TdR for 8 hours before harvest. Radioactivity in 
counts per minute (cpm) was measured using scintillation counting. Results were 
expressed as % inhibition of H^-TdR incorporation, using the untreated JCS as 
control. Each point represents the mean 土 standard error of quadruplicate wells. The 
x-axis was plotted in a logarithmic scale. 
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Figure 5.2: Morphological changes ofATRA-treated JCS cells. JCS cells (lxlO^ 
cells / mI) were mcubated with different concentrations (0-5 _ ofATRA at 37�C for 
72 hours. ^ cells were cytocentnfuged onto the m.croscop.c sHde, and were stamed 
wxth mod^ fied Wnght-G.emsa stam. JCS cells were cultured m [A] culture medunr 
[B] ATRA (0.1 _ ) ; [C] ATRA (1 _ and [D] ATRA (5 _ ) ( M a _ _ n 
x400) 
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Figure 5.3: Synergistic induction of monocytic differentiation by flavone and 
ATRA. JCS cells (lxlO^ cells / ml) were incubated with flavone (12.5 |xM) and^ or 
ATRA (1 i^M) at 37�C for 72 hours. The cells were cytocentrifuged onto the 
microscopic slide，and were stained with modified Wright-Giemsa stain. JCS cells 
were cultured in [A] culture medium; [B] flavone; [C] ATRA and [D] flavone and 
ATRA. (Magnificationx400) 
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5.2.1.2 Modulatory Effects of Flavone and 1,25-dihydroxyvitamin D3 on 
the Proliferation and Differentiation ofJCS Cells 
Early studies showed that 1,25-dihydroxyvitamin D3 fVit. D3) inhibited 
cell growth and induced cell differentiation of leukemia cell lines along 
monocyte-macrophage pathway (Tanaka et al., 1983). Li the present study, 
JCS cells were incubated with various concentrations of flavone (0-25 jnM) 
V 
and Vit. D3 (0-10'^ M) for 48 hours and the proliferation rate was determined 
by tritiated thymidine incorporation. As shown in Figure 5.4, Vit. D3 alone 
exhibited little, if any, anti-proliferative effect on JCS cells when its ; 
concentration was below 1x10'^  M. However, Vit. D3 significantly enhanced 
the growth-inhibitory effect of flavone on JCS cells. 
As shown in Figure 5.5, after incubating JCS cells with Vit. D3 (0-
lxlO_8 jyQ for 72 hours, the cells were induced to differentiate dose 
dependently along the monocytic pathway. On the other hand, JCS cells 
treated with flavone (12.5 pM) or Vit. D3 (lxlO"^ M) alone exhibited little or 
no morphological changes. However, combination of flavone (12.5 pM) and 
i i i ' 
Vit. D3 (lxlO_9 M) acted in synergy in inducing monocytic differentiation of 
JCS cells, as demonstrated by the significant morphological changes of the 
JCS cells to macrophage-like appearance with high cytoplasm to nucleus ratio 
and the presence of large vacuoles (Figure 5.6D). 
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Figure 5.5: Effect of flavone and 1,25-dihydroxyvltamin D3 on the inhibition of 
JCS ceU proliferation. JCS cells (2xl0^ / 200 1^) were incubated at 37�C with "  
flavone (0-25 i^M) in the presence of Vit. D3 (0- 1x10"^  M) for 48 hours. Cultures 
were then pulsed with 0.5 \iCi of^TdR for 8 hours before harvest. Radioactivity in 
counts per minute (cpm) was measured using scintillation counting. Results were 
expressed as % inhibition of ^-TdR incorporation, using the untreated JCS as 
control. Each point represents the mean 土 standard error of quadruplicate wells. The 
x-axis was plotted in a logarithmic scale. 
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Figure 5.5: Morphological changes of 1,25 dihydroxyvitamin D3-treated JCS cells. 
g 
JCS cells (lxlO^ cells / ml) were incubated with different concentrations (0-lxl0" M) 
ofVit. D3 at 37°C for 72 hours. The cells were cytocentrifiiged onto the microscopic 
slide, and were stained with modified Wright<Hemsa stain. JCS cells were cultured in 
[A] culture medium; [B] Vit. D3 (lxlO"^ ^ M); [C] Vit. D3 (lxlO'^ M) and [D] Vit. D3 
(lxlO_8 M) (Magnification x400) 
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Figure 5.6: Synergistic induction of monocytic differentiation by flavone and 1,25-
dihydroxyvitamin D3. JCS cells (lxlO^ cells / ml) were incubated with flavone (12.5 
j^ M) andy'or Vit. D3 (lxlO"^ M) at 37�C for 72 hours. The cells were cytocentrifuged 
onto the microscopic slide, and were stained with modified Wright-Giemsa stain. JCS 
cells were cultured in [A] culture medium; [B] flavone; [C] Vit. D3 and [D] flavone 
and Vit. D3. (Magnification x400) 
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5.2.2 Combinations of Flavone and Cytokines on the Proliferation and 
Differentiation of JCS Cells 
5.2.2.1 Modulatory Effects of Flavone and rmIFN-y on the Proliferation 
and Differentiation of JCS Cells 
As shown in Figure 5.7, raJPN-y alone inhibited the proliferation of 
JCS cells in a dose-dependent manner, but this anti-proliferative activity was 
less potent than flavone, and the maximum inhibition was only about 20% at a 
very high concentration of EFN-y (2000 units/ml). The addition of DFN-y 
significantly enhanced the anti-proliferative effect of flavone on JCS cells. 
On the other hand, EFN-y alone failed to induce the terminal 
differentiation of JCS cells, most of the cells were blocked at the intermediate 
stage of differentiation (Figure 5.8). Although JFN-y can enhance the growth 
inhibitory effect of flavone on JCS cells, but no enhanced effect was observed 
in flavone-induced JCS cell differentiation (data not shown). 
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Figure 5.7: Effect of flavone and rmDFN-y on the inhibition of JCS ceU 
proUferation. JCS cells (2xl0^ / 200 pi) were incubated at 37°C with flavone (0-25 
^M) in the presence of rmffN-y (0-2000 units/ml) for 48 hours. Cultures were then 
pulsed with 0.5 i^Ci of H^-TdR for 8 hours before harvest. Radioactivity in counts 
per minute (cpm) was measured using scintillation counting. Results were expressed 
as % inhibition of ^-TdR incorporation, using the untreated JCS as control. Each 
point represents the mean 土 standard error of quadruplicate wells. The x-axis was 
plotted in a logarithmic scale. 
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Figure 5.8: Morphological changes of mtfFN-y-treated JCS cells. JCS cells (lxlO^ 
cells/ml) were incubated with different concentrations (0-500 units/ml) of mdFN-y at 37°C 
for 72 hours. The cells were cytocentrifuged onto the microscopic slide, and were stained 
with modified Wright-Giemsa stain. JCS cells were cultured in [A] culture medium; [B] 
mdFN-y (10 units/ml); [C] rmIFN-y (100 units/ml) and [D] rmEFN-y (500 units/ml) 
(Magnification x400) 
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5.2.2.2 Synergistic Effects ofFlavone and rmIL-1 on the Proliferation and 
Differentiation ofJCS Cells 
IL-1 was found to induce the differentiation of various myeloid 
leukemia cells into macrophage-like cells (Onozaki et al, 1987). Li this study, 
the JCS cells were incubated with different concentrations of flavone (0-25 
^M) and mJDL-la/raJDL-ip (0-10 ngy^ ml) for 48 hours, and the cell 
proliferation was determined by tritiated thymidine incorporation. As shown 
in Figure 5.9 and Figure 5.10, EL-la or IL-ip alone exhibited a slight 
inhibitory effect on the proliferation of JCS cells, and only about 20% of 
inhibition was observed at a relatively high concentration ofE^-l (10 ngMl). 
However, both types of EL-1 synergistically enhanced the growth-inhibitory 
effect of flavone on JCS cells, and the proliferative responses of JCS cells 
towards these two cytokines at different concentrations of flavone were quite 
similar. 
Different concentrations of EL-la and IL-lp (0-5 ngAnl) induced the 
differentiation of JCS cells along the monocytic pathway in a dose dependent 
manner (Figure 5.11 and Figure 5.12). However, combination of low dose of 
flavone (12.5 ^M) and EL-1 (1 ng/ml) acted in synergy to induce the 
differentiation of JCS cells (Figure 5.13 and Figure 5.14). JCS cells treated 
with both flavone and IL-1 had larger cell size, increase in cytoplasm to 
nucleus ratio and more vacuoles, when compared with JCS cells treated with 
flavone or IL-1 alone. 
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Figure 5.9: Synergistic effect of flavone and rmIL-la on the inhibition of JCS 
cell proliferation. JCS cells (2xl0^ / 200 i^l) were incubated at 37°C with flavone 
(0-25 i^M) in the presence of rmH -^la (0-10 ng/ml) for 48 hours. Cultures were then 
pulsed with 0.5 i^Ci of ^-TdR for 8 hours before harvest. Radioactivity in counts 
per minute (cpm) was measured using scintillation counting. Results were expressed 
as % inhibition of H^-TdR incorporation, using the untreated JCS as control. Each 
point represents the mean 土 standard error of quadruplicate wells. The x-axis was 
plotted in a logarithmic scale. 
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Figure 5.10: Synergistic effect of flavone and rmIL-ip on the inhibition of JCS 
ceU proliferation. JCS cells (2xl0^ / 200 i^l) were incubated at 37°C with flavone (0-
50 i^M) in the presence of raJL-ip (0-10 ng/ml) for 48 hours. Cultures were then 
pulsed with 0.5 i^Ci of ^-TdR for 8 hours before harvest. Radioactivity in counts 
per minute (cpm) was measured using scintillation counting. Results were expressed 
as % inhibition of H^-TdR incorporation, using the untreated JCS as control. Each 
point represents the mean 士 standard error of quadruplicate wells. The x-axis was 
plotted in a logarithmic scale. 
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Figure 5.11 Morphological changes of rmIL-la-treated JCS cells. JCS cells 
(lxlO^ cells / ml) were incubated with different concentrations (0-5 ng/ml) of 
rmIL-la at 37�C for 72 hours. The cells were cytocentrifuged onto the microscopic 
slide, and were stained with modified Wright-Giemsa stain. JCS cells were cultured in 
[A] culture medium; [B] rmIL-la (0.1 ng/ml); [C] rmIL-la (1 ngy^ ml) and [D] 
rmIL-la (5 ng/ml) (Magnification x400) 
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Figure 5.12 Morphological changes ofrmIL-ip-treated JCS cells. JCS cells (1x10 
cells / ml) were incubated with different concentrations (0-5 ngM) of rmIL-ip at 37°C 
for 72 hours. The cells were cytocentrifuged onto the microscopic slide, and were 
stained with modified Wright-Giemsa stain. JCS cells were cultured in [A] culture 
medium; [B] rmIL-ip (0.1 ng/ml); [C] rmIL-ip (1 ngArd) and [D] rmIL-ip (5 ng/ml) 
(Magnification x400) 
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Figure 5.13 Synergistic induction of monocytic differentiation by flavone and 
rmIL-la. JCS cells (lxlO^ cells / ml) were incubated with flavone (12.5 ^M) and/or 
rmIL-la (1 ngAnl) at 37°C for 72 hours. The cells were cytocentrifuged onto the 
microscopic slide, and were stained with modified Wright-Giemsa stain. JCS cells 
were cultured in [A] culture medium; [B] flavone; [C] rmIL-la and [D] flavone and 
rmIL-la. (Magnification x400) 
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Figure 5.14: Synergistic induction of monocytic differentiation by flavone and 
rmIL-ip. JCS cells (lxlO^ cells / ml) were incubated with flavone (12.5 i^M) and/or 
rmIL-ip (1 ng/ml) at 37°C for 72 hours. The cells were cytocentrifuged onto the 
microscopic slide, and were stained with modified Wright<}iemsa stain. JCS cells 
were cultured in [A] culture medium; [B] flavone; [C] rmIL-ip and [D] flavone and 
rmIL-ip. (Magnification x400) 
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5.2.3 Modulation of Cytokine Gene Expression in Flavone-treated JCS 
Cells 
The molecular mechanism by which flavone can induce monocytic 
differentiation of JCS cells was investigated by the method of Reverse 
Transcription-Polymerase Chain Reaction (RT-PCR). JCS cells (lxlO^) were 
incubated with flavone (50 jixM) for different periods of time (8，18 and 48 
hours) and the JCS cells treated with ethanol (0.05%) for 48 hours and the 
untreated JCS cells (lxlO^) were included as control samples. Then the total 
cellular RNAs were isolated, which in tum were reverse transcribed into 
cDNA by priming with oligo-dT. The specifically designed oligonucleotide 
primers (listed in Table 2.2 of Chapter 2) were used for the detection of gene 
expression in different samples ofJCS cells. 
The levels of cytokine gene expression were first analyzed by running 
the PCR products on ethidium bromide-stained agarose gel. The identity of 
the PCR products was then verified by dot-blot hybridization analysis, and 
semi-quantitative analysis was performed by the cycle titration, followed by 
the densitometric scanning of the hybridization signals. The negative control 
containing no cDNA template was included to evaluate the presence of any 
contaminant in the PCR reaction mixture. In some cases, the cDNA sample 
prepared from mouse spleen cells stimulated with concanavalin A (Con A) 
was also co-amplified as a positive control to rule out the possibility of false 
negative. The amount of RNA was normalized by comparison with the 
amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
mRNA(Figure5.15). 
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Figure 5.15: Analysis ofGAPDH gene expression in flavone-treated JCS ceUs by RT-
PCR. JCS cells (1x100 were cultured with flavone (50 ^M) at 37^ C for different periods 
of time (0，8，18 and 48 hours) and ethanol (0.05%) for 48 hours. Total RNAs were 
prepared by using the guanidine thiocyanate-cesium chloride ultracentrifugation. They 
were then reverse transcribed and amplified by PCR for 20 cycles using specific primers. 
The PCR products were then analyzed on ethidium bromide stained 2% agarose gel. The 
position ofthe PCR product was marked by the arrow and its expected size was shown on 
the right. 
Lane 1: 1 kb DNA marker Lane 5: Flavone-treated JCS cells (48 hrs) 
Lane 2: Untreated JCS cells Lane 6: Ethanol-treated JCS ceUs (48 hrs) 
Lane 3: Flavone-treated JCS cells (8 hours) Lane 7: Negative control (no cDNA 
Lane 4: Flavone-treated JCS cells (18 hours) template) 145 
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Certain hematopoietic cytokines are known to control the leukemic cell 
proliferation and induce their differentiation to more mature cells (Sachs, 
1982; Hozumi, 1983; Chabannon and Mannoni, 1994). They function in a 
complex network of interactions in which one cytokine may mediate its effect 
indirectly through the induction of other cytokines. Li the present study, the 
cytokine gene expression profile in flavone-treated JCS cells was analyzed. 
Using the technique ofRT-PCR, low level ofTNF-a mRNA was expressed in 
the unstimulated JCS cells and its level of expression was slightly increased 
upon flavone treatment for 8 hours and reached a maximum at 18 hours 
(Figure 5.16 and Figure 5.17). Then the level of its transcript decreased 
slightly at 48-hour after stimulation with flavone. 
Besides TNF-a, the M-CSF gene expression was also up-regulated 
after flavone treatment. A marked increase in level of M-CSF mRNA was 
observed in JCS cells after 48-hour exposure to flavone OE^ igure 5.18 and 
Figure 5.19). Li contrast, the solvent used in dissolving flavone, ethanol 
(0.05%) had a slight inhibitory effect on the M-CSF mRNA expression level 
on the JCS cells, at 48-hour ofincubation. 
Leukemia inhibitory factor (LEF), was found to cause monocytic 
differentiation of Ml myeloid leukemia cells. The expression level of LEF 
gene in JCS cells was studied in this project. It was found that flavone 
induced the expression of LEF gene in JCS cells at 48 hours after exposure to 
flavone. Although no visible band was observed after gel electrophoresis 
(Figure 5.20), but the dot blot hybridization analysis revealed the expression 
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Figure 5.16: Analysis of TNF-a gene expression in flavone-treated JCS cells by RT-
PCR. JCS cells (1x100 were cultured with flavone (50 i^M) at 37°C for different periods 
of time (0, 8，18 and 48 hours) and ethanol (0.05%) for 48 hours. Total RNAs were 
prepared by using the guanidine thiocyanate-cesium chloride ultracentrifugation. They 
were then reverse transcribed and amplified by PCR for 25 and 30 cycles using specific 
primers. The PCR products were then analyzed on ethidium bromide-stained 2% agarose 
gel. The position ofthe PCR product was marked by the arrow and its expected size was 
shown on the right. 
Lane 1: 1 kb DNA marker Lane 5: Flavone-treated JCS cells (48 hrs) 
Lane 2: Untreated JCS cells Lane 6: Ethanol-treated JCS cells (48 hrs) 
Lane 3: Flavone-treated JCS cells (8 hours) Lane 7: Negative control (no cDNA 
Lane 4: Flavone-treated JCS cells (18 hours) template) 
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Figure 5.17: O p^per panel) Semi-quantitative dot blot analysis of TNF-a gene 
expression in flavone-induced JCS cell differentiation. 15 i^l of each type ofthe RT-
PCR products was dotted onto the positive-charged nylon membrane, and hybridized to a 
DIG-labeled internal probe specific for each gene. Chemiluminesent detection was 
performed on exposure to X-ray flhn. (Lower panel) Densitometric analysis of the 
hybridization signal. Quantitative analysis of hybridization signals of the dot blot 
(30 cycles) was demonstrated by densitometric scanning. 
Lane 1: Untreated JCS cells Lane 4: Flavone-treated JCS cells (48 hrs) 
Lane 2: Flavone-treated JCS cells (8 hours) Lane 5: Ethanol-treated JCS cells (48 hrs) 
Lane 3: Flavone-treated JCS cells (18 hours) Lane 6: Negative control (no cDNA 
template) 
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Figure 5.18: Analysis ofM-CSF gene expression in flavone-treated JCS ceUs by RT-
PCR. JCS cells (1x100 were cultured with flavone (50^M) at 37�C for different periods 
of time (0，8, 18 and 48 hours) and ethanol (0.05%) for 48 hours. Total RNAs were 
prepared by using the guanidine thiocyanate-cesium chloride ultracentrifugation. They 
were then reverse transcribed and amplified by PCR for 20，25 and 30 cycles using 
specific primers. The PCR products were then analyzed on ethidiiun bromide stained 
2% agarose gel. The position of the PCR product was marked by the arrow and its 
expected size was shown on the right. 
Lane 1: 1 kb DNA marker Lane 5: Flavone-treated JCS cells (48 hrs) 
Lane 2: Untreated JCS cells Lane 6: Ethanol-treated JCS cells (48 hrs) 
Lane 3: Flavone-treated JCS cells (8 hours) Lane 7: Negative control (no cDNA 
Lane 4: Flavone-treated JCS cells (18 hours) template) 
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Figure 5.19: OUpper panel) Semi-quantitative dot blot analysis of M-CSF gene 
expression in flavone-induced JCS cell differentiation. 15 1^ of each type of the RT-
PCR products was dotted onto the positive-charged nylon membrane, and hybridized to a 
DIG-labeled internal probe specific for each gene. Chemiluminesent detection was 
performed on exposure to X-ray fihn. (Lower panel) Densitometric analysis of the 
hybridization signal. Quantitative analysis of hybridization signals of the dot blot 
(20 cycles) was demonstrated by densitometric scanning. 
Lane 1: Untreated JCS cells Lane 4: Flavone-treated JCS cells (48 hrs) 
Lane 2: Flavone-treated JCS cells (8 hours) Lane 5: Ethanol-treated JCS cells (48 hrs) 
Lane 3: Flavone-treated JCS cells (18 hours) Lane 6: Negative control (no cDNA 
template) 
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Figure 5.20: Analysis of LIF gene expression in flavone-treated JCS cells by RT-
PCR. JCS cells (1x100 were cultured with flavone (50 {iM) at 37°C for different periods 
of time (0，8, 18 and 48 hours) and ethanol (0.05%) for 48 hours. Total RNAs were 
prepared by using the guanidine thiocyanate-cesium chloride ultracentrifogation. They 
were then reverse transcribed and amplified by PCR for 40 cycles using specific primers. 
The PCR products were then analyzed on ethidimn bromide stained 2% agarose gel. The 
position ofthe PCR product was marked by the arrow and its expected size was shown on 
the right. 
Lane 1: Con-A stimulated spleen cells Lane 5: Flavone-treated JCS cells (18 hrs) 
Lane 2: 1 kb DNA marker Lane 6: Flavone-treated JCS cells (48 hrs) 
Lane 3: Untreated JCS cells Lane 7: Ethanol-treated JCS cells (48 hrs) 
Lane 4: Flavone-treated JCS cells Lane 8: Negative control (no cDNA 
(8 hours) template) 
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Figure 5.21: OUpper panel) Semi-quantitative dot blot analysis of LW gene 
expression in flavone-induced JCS cell differentiation. 15 1^ of each type ofthe RT_ 
PCR products was dotted onto the positive-charged nylon membrane, and hybridized to a 
DIG-labeled internal probe specific for each gene. Chemilmninesent detection was 
performed on exposure to X-ray fihn. (Lower panel) Densitometric analysis of the 
hybridization signal. Quantitative analysis of hybridization signals of the dot blot 
(40 cycles) was demonstrated by densitometric scanning. 
Lane 1: Untreated JCS cells Lane 4: Flavone-treated JCS cells (48 hrs) 
Lane 2: Flavone-treated JCS cells (8 hours) Lane 5: Ethanol-treated JCS cells (48 hrs) 
Lane 3: Flavone-treated JCS cells (18 hours) Lane 6: Negative control (no cDNA 
template) 
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Ln Section 5.2.2.2, rmIL-1 was shown to synergize with flavone in 
regulating the growth and differentiation of JCS cells, suggesting that IL-1 
may play an important role in the differentiation of myeloid leukemia JCS 
cells. Lti this study, an up-regulation of EL-la mRNA level was observed in 
JCS cells during monocytic differentiation induced by flavone. A prominent 
induQtion of JL-la gene expression was observed as shown in the dot-blot 
hybridization analysis, after exposure to flavone for 48 hours (Figure 5.22), 
but no DNA band was detected on the agarose gel (Figure 5.23). The failure 
of detecting the BL-la PCR products on the agarose gel may be due to the 
limited sensitivity of ethidium bromide staining. 
I 
As shown from the dot-blot hybridization analysis (Figure 5.24), the ； 
？ 




expression was down-regulated at 18 hours but up-regulated after exposure to | 
flavone for 48 hours. On the other hand, no DNA band was observed on the ^ 
agarose gel (Figure 5.25), and this may due to the limited sensitivity of the 
ethidium bromide staining. 
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Figure 5.22: ^Upper panel) Semi-quantitative dot blot analysis of BL-la gene 
expression in flavone-induced JCS cell differentiation. 15 1^ ofeach type ofthe RT_ 
PCR products was dotted onto the positive-charged nylon membrane, and hybridized to a 
DIG-labeled internal probe specific for each gene. Chemiluminesent detection was 
performed on exposure to X-ray fihn. (Lower panel) Densitometric analysis of the 
hybridization signal. Quantitative analysis of hybridization signals of the dot blot 
(40 cycles) was demonstrated by densitometric scanning. 
Lane 1: Untreated JCS cells Lane 4: Flavone-treated JCS cells (48 hrs) 
Lane 2: Flavone-treated JCS cells (8 hours) Lane 5: Ethanol-treated JCS cells (48 hrs) 
Lane 3: Flavone-treated JCS cells (18 hours) Lane 6: Negative control (no cDNA 
template) 
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Figure 5.23: Analysis of BL-la gene expression in flavone-treated JCS ceUs by RT-
PCR. JCS cells (1x100 were cultured with flavone (50 i^M) at 37�C for different periods 
of time (0，8, 18 and 48 hours) and ethanol (0.05%) for 48 hours. Total RNAs were 
prepared by using the guanidine thiocyanate-cesium chloride ultracentrifugation. They 
were then reverse transcribed and amplified by PCR for 40 cycles using specific primers. 
The PCR products were then analyzed on ethidimn bromide stained 2% agarose gel. The 
position ofthe PCR product was marked by the arrow and its expected size was shown on 
the right. 
Lane 1: Con-A stimulated spleen cells Lane 5: Flavone-treated JCS cells (18 hrs) 
Lane 2: 1 kb DNA marker Lane 6: Flavone-treated JCS cells (48 hrs) 
Lane 3: Untreated JCS cells Lane 7: Ethanol-treated JCS cells (48 hrs) 
Lane 4: Flavone-treated JCS cells Lane 8: Negative control (no cDNA 
(8 hours) template) 
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Figure 5.24: (^pper panel) Semi-quantitative dot blot analysis of BL-6 gene 
expression in flavone-induced JCS cell differentiation. 15 p,l of each type of the RT-
PCR products was dotted onto the positive-charged nylon membrane, and hybridized to a 
DIG-labeled internal probe specific for each gene. Chemiluminesent detection was 
performed on exposure to X-ray fihn. (Lower panel) Densitometric analysis of the 
hybridization signal. Quantitative analysis of hybridization signals of the dot blot 
(40 cycles) was demonstrated by densitometric scanning. 
Lane 1: Untreated JCS cells Lane 4: Flavone-treated JCS cells (48 hrs) 
Lane 2: Flavone-treated JCS cells (8 hours) Lane 5: Ethanol-treated JCS cells (48 hrs) 
Lane 3: Flavone-treated JCS cells (18 hours) Lane 6: Negative control (no cDNA 
template) 
— lJ2 
Ch. 5 Mechanistic Studies ofJCS Cells 
1 2 3 4 5 6 7 8 
等_攀^^^‘、'’ 
S ‘ . . ； ‘ , ‘ • 
m .. ^ - ‘ :、 T^ ^ , ‘ ‘ “ / ‘ ” ‘ -
；.:',;^,!i':^;';|^'p:p^^  • 
1 0 1 8 b p _、，>:.:,::,:::嘴、:,:'；^:".”.、.:;: 
• /- . ./ '":"-/^U-y1^-j^><-'>r''r ',, ‘ . • 
-A0mim^m^^^^^^^^rnmmmmmmm 
"“：“,枕','々離:'7 'j/; 
‘'''：:.‘''::产嚷一:轉3‘、:八/“::、‘： ^ '• _:,::。::邏|1麵'e-::‘:: r -1 \ _ 479 bp 
396 bp '>^;�.广广«擎.4, V :;>,/" …，叩 
J 7 " " P 參 德>』厂。：：'K:' …’ 
. ‘ , ^ ¾ * ¾ : : 
. , 霍 . 
, 缚 . ^ 雜 . . : ， 
‘ / ' V ' ' s , > ' "^ \ ' / / ' ^ ^ > > ‘ ' ' , ' 、 , “ V " ‘ ‘ ‘ ‘ ‘',r !,?;^e;,::々 •. ：•• "r-^ — , ‘,-；-:«'： ^;,'；:：^：' <• 
‘ ‘ ,-.'/' ^, 、 ^ ' ‘ '"•' - • 一 
40 cycIes 
Figure 5.25: Analysis of EL-6 gene expression in flavone-treated JCS ceUs by RT-
PCR. JCS ceUs (1x100 were cultured with flavone (50 i^M) at 37°C for different periods 
of time (0, 8, 18 and 48 hours) and ethanol (0.05%) for 48 hours. Total RNAs were 
prepared by using the guanidine thiocyanate-cesimn chloride ultracentrifugation. They 
were then reverse transcribed and amplified by PCR for 40 cycles using specific primers. 
The PCR products were then analyzed on ethidium bromide stained 2% agarose gel. The 
position of the PCR product was marked by the arrow and its expected size was shown on 
the right. 
Lane 1: Con-A stimulated spleen cells Lane 5: Flavone-treated JCS cells (18 hrs) 
Lane 2: 1 kb DNA marker Lane 6: Flavone-treated JCS cells (48 hrs) 
Lane 3: Untreated JCS cells Lane 7: Ethanol-treated JCS ceUs (48 hrs) 
Lane 4: Flavone-treated JCS cells (8 hours) Lane 8: Negative control (no cDNA 
template) 
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5.3 DISCUSSION 
The method of differentiation therapy for leukemia is based on the 
activity performed by a variety of physiological and non-physiological 
inducers which can release the block imposed on the hematopoietic pathway, 
so that the balance between proliferation, differentiation and apoptosis can be 
restored (Sachs, 1978; Hozumi, 1983). Jn addition, a more effective method in 
utilizing this differentiation therapy is the combinations of various 
differentiation- and apoptosis- inducers, which can work through different 
receptors and signal transduction pathways. As a result, lower and non-
cytotoxic concentrations of inducers are used with higher therapeutic efficacy 
and the malignant clone will be eliminated before the resistance can be 
developed (Zhang et aL, 1992; Elstner et al., 1996). 
Ln this study, the combination effects of flavone, vitamin analogs and 
cytokines on the proliferation and differentiation of leukemia JCS cells were 
investigated. It was found that ATRA and 1,25-dihydroxyvitamin D3 
significantly enhanced the anti-proliferative effect of flavone on JCS cells. 
Moreover, the combination of flavone and ATRA or 1,25-dihydroxyvitamin 
D3 acted synergistically in inducing monocytic differentiation ofleukemia JCS 
cells in vitro (Section 5.2.1.1 and Section 5.2.1.2). Similar observations were 
made on rmIL-la and rmIL-lp (Section 5.2.2.2). It was demonstrated that 
flavone and rmIL-1 acted in synergy in inhibiting the growth and in inducing 
monocytic differentiation of JCS cells. In contrast, rmIFN-y failed to synergize 
with flavone in triggering the differentiation of JCS cells (Section 5.2.2.1). 
The simultaneous addition of sub-optimal concentrations of flavone and 
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rmJFN-Y to JCS cells failed to induce the terminal differentiation of the 
leukemia cells. On the other hand, rmffN-y significantly enhanced the 
inhibitory effect of flavone on the proliferation of JCS cells, which suggested 
that the proliferation can be dissociated from the differentiation process. 
Results from this study indicate that JCS can differentiate along the 
monocytic pathway in response to different inducers including flavone, 
cytokines and physiological inducers such as vitamin analogs. However, the 
mechanism(s) whereby flavone and these physiological inducers can 
synergistically exert their effects on JCS cell differentiation remain(s) unclear. 
Whether they induce the differentiation of JCS cells by direct action or 
indirectly by inducing the production of other secondary cytokines has yet to 
be established. 
Our results, though preliminary, do suggest that the combinations of 
flavone and rmEL-1 or physiological inducers such as ATRA & 1，25-
dihydroxyvitamin D3, may have potential value for the differentiation therapy 
for some forms of leukemia. Furthermore, the combined use of flavone, 
physiological inducers and cytokines may have benefits over the use of single 
one, since a much greater therapeutic effect can be attained with lower non-
cytotoxic doses and the possibility for the development of drug resistance 
could also be reduced. 
It is well known that cell differentiation depends on the program of 
ordered gene expression in modulating the specific proteins involved in the 
expression ofa specific, terminally differentiated phenotype. Furthermore, the 
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hematopoietic cytokines can act as positive or negative regulators of myeloid 
cell differentiation and they are organized in a complex network (Sachs, 1987; 
Lotem et al., 1991; Whetton and Dexter, 1993). Thus, the study of cytokine 
gene expression during leukemic cell differentiation will provide a better 
insight into the modulation of cellular response by cytokines. Ln this chapter, 
using RT-PCR, it was shown that flavone could modulate the expression of 
several cytokine genes such as TNF-a, M-CSF, UF, R,-la and IL-6 during 
the monocytic differentiation ofJCS cells. Similarly, it has been reported that 
flavone acetic acid can also induce cytokine gene expression, such as TNF-a, 
EFN-a/p and y in various cell types, including leukemia, macrophages and 
renal cancer cell lines (Mace et aL, 1990; Futami et al., 1991; Ching et aL, 
1994; Eader etaL, 1994). 
Tumor necrosis factor-a (TNF-a) is primarily a 
monocyte/macrophage-derived cytokine with multiple biological activities in 
inflammation and in regulation of immune response. TNF-a has been shown 
to suppress the proliferation of early hematopoietic progenitors of bone 
marrow cells (Witsell and Schook, 1992). It is also a potent inducer and 
triggers the differentiation of JCS cells into mature macrophage-like cells 
(Mak et al., 1993). Jn this study, during the monocytic differentiation ofJCS 
cell induced by flavone, the expression of TNF-a gene was shown to be 
enhanced at 18-hour after treatment and the expression level was then reduced 
slightly at 48 hours after exposure to flavone. A similar pattem of transient 
TNF-a gene expression was also observed in the PMA-induced monocytic 
differentiation of the JCS cells (Mak et aL, 1993). Although it has been 
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reported that TNF-a alone can act as a signal for induction of differentiation 
of JCS cells (Mak et al., 1993; Leung et aL, 1994), whether the transient up-
regulation of TNF-a gene expression may play a role in the flavone-induced 
monocytic differentiation of JCS cells remains to be established. 
Apart from TNF-a, the up-regulation in the level of M-CSF gene 
expression in flavone-treated JCS cells was also observed in the present study. 
Since M-CSF is one of the colony-stimulating factors that can stimulate the 
formation of macrophage colonies from bone marrow progenitor cells (Das et 
al., 1981; Metcalf and Burgess, 1982), it is not surprising that it may play a 
role in the monocytic differentiation of the leukemia JCS cells. Our results are 
consistent with Lotem et al. (1991) who showed that IL-6 or GM-CSF 
triggered myeloid leukemic cell differentiation was associated with the 
induction ofM-CSF gene expression. 
Leukemia inhibitory factor (LEF) was first discovered to cause 
monocytic differentiation ofthe Ml leukemia cell line. The expression level 
of LEF was also found to be up-regulated at 48 hours after flavone treatment, 
when JCS cells were induced to differentiate along the monocytic pathway. 
Since it has been shown that LEF alone does not trigger JCS cell differentiation 
(Lau, 1996)，therefore, the significance for the induction of UF gene 
expression in flavone-treated JCS cells remains obscure. 
As shown in Section 5.2.2.2, both rmIL-la and rmIL-ip acted in 
synergy with flavone in inhibiting proliferation and in inducing monocytic 
differentiation of JCS cells. Li the present study, a remarkable up-regulation 
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of EL-la expression was observed at the later stage (48 hours) of JCS cells 
after treatment with flavone. Since IL-la is readily produced by 
macrophages, it is possible that the increased production of this cytokine by 
flavone-triggered JCS cells at a late time point (48 hours) may be correlated 
with cell maturation and acquisition ofmacrophage functions. Li addition, our 
fmdings are in agreement with a recent report showing that exogenous EL-1 is 
an effective inducer of JCS cell differentiation and that this cytokine may be 
involved, at least in part, in TNF-a-induced monocytic differentiation of the 
leukemia JCS cells (Chan et aL, 1997). 
Merleukin-6 (IL-6) has been reported to maintain the viability and 
induce the differentiation of normal myeloid precursor cells O o^tem et aL, 
1989; Devereux and Linch, 1990). Moreover, Gothelf and co-workers (1991) 
also showed that EL-6 could induce the terminal differentiation of the 
myeloleukemic Ml cells. Lti the present study, using dot blot hybridization, 
unstimulated JCS cells were found to express a basal level ofK^-6 gene, and it 
was downregulated slightly upon flavone treatment at the first 8 and 18 hours. 
However, the EL-6 gene expression was up-regulated at 48 hours after 
incubation with flavone. The significance for the transient down-regulation of 
IL-6 gene expression by flavone treatment remains unclear and requires 
further investigation. 
]n conclusion, the expression of several cytokine genes was found to 
be modulated in the flavone-induced monocytic differentiation of myeloid 
leukemia JCS cells. Further studies on the interplay of these cytokines, their 
receptors and the signal transduction pathways involved in the cell 
m 
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differentiation may provide better insight into the molecular mechanisms by 





AND FUTURE PERSPECTIVES 
Ch.6 Conclusions & Future Perspectives 
Hematopoiesis is a homeostatic blood cell forming process maintained 
between the proliferation and differentiation of the hematopoietic stem cells 
and progenitor cells, which is tightly regulated by a group of hematopoietic 
cytokines (Dexter and Spooncer，1987; Hoffbrand and Pettit, 1993). 
Leukemia may be viewed as an uncoupling of the proliferation, differentiation 
and survival of hematopoietic cells occurring at various stages along the 
hematopoietic pathway. Li case of myeloid leukemia, the immature 
myeloblasts retain their self-renewal capacity and are blocked to differentiate 
into mature cells (Sachs, 1982; Campbell, 1995). A number of myeloid 
leukemia cell lines have been isolated and cloned, and the genetic 
abnormalities in leukemia can be bypassed with a variety of exogenously 
added differentiation-inducing agents, in which the cells are induced to 
differentiate into mature granulocytes or macrophages (Sachs, 1978; Hozumi, 
1983). 
The underlying mechanism of hematopoiesis can be investigated by 
studying the induced cell differentiation of a murine myeloid leukemia cell 
line, WEffl-3B JCS (Mak et aL, 1993). Like many other well-characterized 
cell models, this cell line can be induced to differentiate by defmed inducers, 
such as PKC activator (phorbol 12-myistate 13-acetate, PMA), bacterial 
product (lipopolysaccharide, LPS) and cytokines (E^-la，IL-lp，TNF-a, 
TNF-a+IL-4 and TNF-a+EFN-丫）(Mak et aL, 1993; Leung et al., 1994; Chan 
ef al.’ 1995). In addition, this cell line was subcloned and can cause acute 
leukemia when serially transplanted into syngeneic mice (Mak et al., 1993), 
thus providing a useful means for the study of differentiated leukemia cells in 
vivo. 
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Naturally occurring low molecular weight plant flavonoids are an 
important part of human diet and have been known to be the active principles 
in some medicinal plants (Boik, 1996). They have been found to have diverse 
biological and pharmacological activities, and may have potentially beneficial 
effects in human health (Middleton, 1996). The most abundant types of 
flavonoids are flavones and flavonols. There is increasing evidence showing 
that flavonoids can regulate the growth and differentiation of a variety of 
leukemia cells in vitro, yet the precise mechanisms by which flavonoids can 
modulate the proliferation, differentiation and survival of leukemia cells are 
poorly understood. Li this study, both flavone and 3-hydroxyflavone 
(flavonol) were found to be potent anti-proliferative agents for the murine 
myeloid leukemia WEHI-3B JCS cells (Chapter 3). Li addition, flavone was 
found to inhibit the in vitro colony-forming ability, the in vivo tumorigenicity 
as well as inducing apoptosis of the JCS cells in vitro. Moreover, the 
monocytic differentiation of JCS cells was also triggered by both flavone and 
flavonol, as shown by increased plastic adherence and the acquisition of 
mature macrophage phenotype, the enhanced expression of macrophage-
differentiation antigens (>Iac-l and F4/80), stimulation of endocytic and 
phagocytic activities, as well as induction of non-specific esterase and 
nitroblue tetrazolium QSBT) dye-reducing activities (Chapter 4). Although 
flavonoids were found to have the capacity to induce myeloid leukemic cell 
differentiation in vitro, whether they will work in vivo as they did in vitro has 
yet to be established. Moreover, the underlying cellular and molecular 
mechanisms by which flavonoids can exhibit their anti-proliferative and 
differentiation-inducing effects on JCS cells remain to be clarified. One 
hypothesis is that flavonoids can exert their action through interactions with 
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the type H estrogen binding site (type H EBS) on the surface of leukemia cells 
{Larocca et al., 1990，1991). Following this interaction, the molecular events 
and signal transduction mechanisms involved in mediating the effects of 
flavonoids on leukemia cells are not fully understood. Certain hematopoietic 
regulators may be involved in this case. As shown in Chapter 5, the 
expression of certain cytokine genes, including TNF-a, M-CSF, LW, EL-la 
and IL-6 were enhanced at the transcription level during the course offlavone-
induced differentiation of the leukemia JCS cells. Whether the protein 
expression levels of these genes are also up-regulated required further 
investigation, ki addition, it was found that flavone can exhibit synergistic 
effect with all-trans retinoic acid (ATRA), 1,25-dihydroxyvitamin D3 and EL-1 
in inducing monocytic differentiation of JCS cells, but the exact mechanism 
underlying this synergism has yet to be determined. 
The number of cells in any tissue is dependent on the balance between 
cell gain by proliferation and cell loss by differentiation and;'or cell death, and 
much attention has been focused on the therapeutic potential of apoptosis in 
treating leukemia (Sen and D'][ncalci, 1992; Green et aL, 1994; Chapman et 
al., 1996). Apoptosis is a form of cell death by committing suicide and is 
characterized by DNA degradation into sizes of 180- to 200-base pair 
fragments (DNA ladder) cleaved by endogenous endonuclease(s) (Sachs and 
Lotem, 1993). In the present study, using agarose gel electrophoresis, the 
characteristic DNA fragmentation was observed in flavone-induced 
differentiating JCS cells. Moreover, the apoptotic morphology changes 
including chromatin condensation and nuclear fragmentation were also elicited 
by flavone (Section 3.2.6). The apoptotic traits were observed along with the 
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induction of monocytic differentiation of JCS cells, and this suggested that 
apoptosis might play a role in the differentiation of myeloid leukemia cells. 
Therefore, further investigation is required to unravel the relationship between 
cell differentiation and apoptosis. 
Recent studies showed that the biological activities of flavonoids, 
especially the growth-inhibitory actions, were mediated through the binding 
interaction with type E estrogen binding sites (type II EBS). These sites were 
originally found in rat uterus (Clark et al., 1978), which display the same 
steroid and tissue specificity, and are distinct from the "true" estrogen receptor 
(ER). They are present in higher concentrations than ER, but have a lower 
apparent affmity constant (Ko = 10-20 nM) for estradiol (E2) than ER 
(Ko 二 0.2-1 nM) (Scambia et al., 1990; 1991 and 1993). They are commonly 
found in various tissues and cancer cell lines, including uterus, ovary, 
hematopoietic cells, human breast cancer MCF-7 cells, human ovarian cancer 
OVCA 433 cells, acute promyelocytic leukemia HL-60 cells, as well as 
various human acute myeloid leukemia (AML) and acute lymphoid leukemia 
(ALL) cell lines (Larocca et aL, 1990 and 1991; Scambia et aL, 1990，1991 
and 1993). Larocca and co-workers (1990 and 1991) showed that the 
flavonol, quercetin, inhibited leukemic cell growth without suppressing 
normal myelopoiesis, and this action was mediated through its interaction with 
the type II EBS. Apart from flavonol, the isoflavones genistein and flavanone 
naringenin can also bound to the type II EBS, and exert certain degree of 
growth inhibitory effect on cancer cells (Ruh et al., 1995; Zava and Duwe, 
1997). Therefore, further investigation will be required to study the 
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relationship between anti-proliferation, differentiation-induction and the 
receptor binding ability of flavone and flavonol on JCS cells. 
The underlying signal transduction mechanisms involved in the 
regulation of leukemic cell proliferation and differentiation by flavonoids have 
not yet been fully elucidated. Flavonoids were found to affect various signal 
transduction pathways, and a variety of enzymes including phospholipase A2 
(PLA2), protein kinase C，protein tyrosine kinases, phospholipase C and 
phospholipase D were inhibited by flavonoids 0VLiddleton and Kandaswami, 
1993; Middleton, 1996). Recent studies showed that flavonoids such as 
genistein and quercetin could inhibit the tyrosine kinase activity ofthe growth 
factor receptors OEGF-, PDGF-, insulin and IGFs-receptors) and oncogene 
products (Srivastava, 1985; Kuo et aL, 1994; Pagliacci et aL, 1994). In order 
to elucidate the intracellular signaling pathways in flavonoid-induced 
leukemic cell differentiation and to identify some of the second messenger 
molecules that may be involved, inhibitors of certain elements ofthe signaling 
pathways can be used. For instance, the protein kinase inhibitor sphingosine, 
calmodulin antagonist W7, the non-specific protein kinase inhibitor H7 and 
the tyrosine kinase inhibitor tyrphostin can be used to determine whether the 
absence of any of these elements can abrogate the growth-inhibition and^ or 
differentiation-inducing activity of flavonoids on JCS cells. As a result, 
further studies on the signal transduction mechanisms of flavonoids are 
required to elucidate the biochemical basis and post-receptor events that may 
be instrumental to myeloid leukemic cell growth, differentiation and survival. 
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Li conclusion, results obtained in this study have demonstrated that 
flavonoids may play a role in regulating myeloid leukemic cell growth and 
differentiation in vitro. It is hoped that better understanding of the molecular 
basis and signal transduction mechanisms involved in leukemic cell 
proliferation, differentiation and survival can lead to the development of more 
specific and less toxic therapeutic strategies for some forms ofleukemia. 
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